###begin article-title 0
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
###end article-title 0
###begin p 1
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 159 164 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 811 816 811 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 821 826 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 878 883 878 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 888 893 888 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 288 296 <span type="species:ncbi:9606">patients</span>
###xml 963 971 <span type="species:ncbi:9606">patients</span>
Specific mutations in BRCA1 and BRCA2 genes have been identified in specific populations and ethnic groups. However, little is known about the contribution of BRCA1 and BRCA2 mutations to breast cancers in the Indonesian population. One hundred-twenty moderate to high risk breast cancer patients were tested using PCR-DGGE, and any aberrant band was sequenced. Multiplex ligation-dependent probe amplification (MLPA) was performed on all samples to detect large deletions in the two genes. Twenty-three different mutations were detected in 30 individuals, ten were deleterious mutations and 20 were "unclassified variants" with uncertain clinical consequences. Three of seven (c.2784_2875insT, p.Leu1415X and del exon 13-15) and two of four (p.Glu2183X and p.Gln2894X) deleterious mutations that were found in BRCA1 and BRCA2 respectively, are novel. Several novel, pathogenic BRCA1 and BRCA2 germline mutations are found in early onset Indonesian breast cancer patients, these may therefore be specific for the Indonesian population.
###end p 1
###begin title 2
Keywords
###end title 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 292 293 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 377 378 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 498 499 498 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 501 502 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 43 48 <span type="species:ncbi:9606">women</span>
###xml 381 386 <span type="species:ncbi:9606">Women</span>
Breast cancer is the most common cancer in women. In 5% to 10% of breast cancer cases, the disease results from a hereditary predisposition [1, 2], which can to a large extent be attributed to mutations in either of two tumour suppressor genes, BRCA1 (MIM# 113705) and BRCA2 (MIM# 600185) [3-5]. These genes are involved in DNA repair as well as transcriptional regulation [6, 7]. Women carrying pathogenic germline mutations in either of these genes tend to develop breast cancer at an early age [8, 9].
###end p 4
###begin p 5
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 125 130 125 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 329 334 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 346 351 346 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 804 809 804 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 814 819 814 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
The BRCA1 and BRCA2 genes encode large proteins of 1,863 and 3,418 amino acids, respectively. Over 300 distinct mutations in BRCA1 and BRCA2 have been described [10, 11]. These mutations are widely scattered across both genes and most affect the structure and function of the gene. Nevertheless, a significant proportion (34% of BRCA1 and 38% of BRCA2 mutations) (http://www.nhgri.nih.gov/Intramural_research/Lab_transfer/Bic) are missense mutations that alter one amino acid, but do not truncate the protein and are rare sequence variants of unknown functional consequence. Moreover, a number of base substitutions do not alter the amino acid sequence or result in amino acid changes not associated with disease (polymorphisms) [12]. Hence the biggest challenge in interpreting the mutation analysis of BRCA1 and BRCA2 genes is to distinguish between harmless polymorphisms and deleterious mutations associated with increased cancer risk.
###end p 5
###begin p 6
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 210 215 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 357 362 357 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 363 368 363 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 491 496 491 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 708 713 708 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 718 723 718 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 860 868 <span type="species:ncbi:9606">patients</span>
In addition, mutations specific for certain populations and ethnic groups have been identified in both genes. For example, specific BRCA1 and BRCA2 mutations were reported for Ashkenazi Jews [13]. Other common BRCA1 mutations were especially found in Italian, Canadian, Belgian or Dutch breast cancer families [14-16]. In Indonesia, the contribution of the BRCA1/BRCA2 mutations to the population incidence of early-onset breast cancer is largely unknown. In one pilot study, however, a new BRCA2 mutation was identified [17] indicating that it was worthwhile to more extensively study the Indonesian population, which was the aim of this study. The accumulating knowledge about the prevalence and nature of BRCA1 and BRCA2 mutations in specific populations may facilitate the interpretation of genetic analysis with regard to breast cancer risk of individual patients.
###end p 6
###begin title 7
Materials and methods
###end title 7
###begin title 8
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 8
###begin p 9
###xml 366 367 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 448 449 448 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 517 518 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 554 555 554 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 39 47 <span type="species:ncbi:9606">patients</span>
###xml 210 218 <span type="species:ncbi:9606">patients</span>
A total of 120 unrelated breast cancer patients and 16 of their family members from three Indonesian cities (Jakarta and Jogjakarta on the Java island, Denpasar on the Bali island) were analyzed. Breast cancer patients at moderate to high-risk of a hereditary predisposition were selected according to the following criteria: (A) Breast cancer before the age of 41 (n = 102); (B) Two cases of breast cancer in the same family before the age of 60 (n = 9); (C) Three or more cases of breast cancer in the same family (n = 2); (D) Bilateral breast cancer (n = 7). Subjects were asked to fill out questionnaires to evaluate their personal and family histories, and blood specimens were collected for determination of BRCA mutations. Informed consent was obtained from all the subjects in this study.
###end p 9
###begin title 10
DNA extraction and PCR amplification
###end title 10
###begin p 11
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 703 705 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
Genomic DNA was isolated by the saturated salt extraction procedure as described in [18]. All 22 coding exons of BRCA1 and 26 coding exons of BRCA2 were amplified using primer sequences developed by the University of Groningen, The Netherlands [19]. Primers for DGGE were obtained from Ingeny (Goes, The Netherlands). Genomic DNA was amplified using 100-200 ng of template DNA, 10 pmol of the mixture of 40-mer primers, 30 mM of MgCl, 3 mM dNTPs (Invitrogen) and 0.7 unit of Platinum Taq (Invitrogen) in 9 mul PCR reactions. In order to speed up the test, the PCR reaction was placed in 384 well plates using a pipetting robot (TECAN Miniprep 75). PCR conditions were performed as previously described [17].
###end p 11
###begin title 12
Denaturing Gradient Gel Electrophoresis and DNA sequencing
###end title 12
###begin p 13
###xml 129 131 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
A 4-6 mul aliquot of each PCR product with relatively large melting temperature differences were pooled as previously described [17] with some modifications for optimal results. The fragment pool was designed based on melting profiles and sequence. Electrophoresis was performed in 0.5 TAE buffer at 58degreesC, 120 V for 16 h for BRCA1 gene, and 55degreesC, 100 V for 18 h for BRCA2. Gels were stained with ethidium bromide and photographed under a UV transilluminator. The aberrantly migrating samples were re-amplified using sequencing primers and sequencing was performed using Big Dye Cycle-sequencing kit according to the manufacturer's instructions. The reaction products were analyzed using an ABI 3100 DNA Sequencer (Applied Biosystems, Torrence, CA, USA) and sequence files were edited using the Bio Edit program. The classification of gene alterations was performed in accordance with the entries in the Breast Cancer Information Core (BIC, Bethesda, MD).
###end p 13
###begin title 14
Multiplex ligation-dependent probe amplification (MLPA)
###end title 14
###begin p 15
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
The principle of the MLPA technique has been described elsewhere [20]. The MLPA test for BRCA1 (P02) and BRCA2 (P45) mutations were obtained from MRC-Holland, Amsterdam, The Netherlands. The fragments were analyzed on an ABI model 310 capillary sequencer (Applied Biosystems, Torrence, CA, USA) using Genescan-TAMRA 500 size standards (Applied Biosystems). Fragment analysis was performed with Genescan software.
###end p 15
###begin title 16
Results and discussions
###end title 16
###begin p 17
We identified 120 incident Indonesian breast cancer cases diagnosed before the age of 41 years, or having family history of breast cancer, or harboring bilateral breast cancer during September 1999-April 2005 (Jogjakarta) and during July 2004-April 2005 (Jakarta and Denpasar). In addition, 16 of their family members were analyzed.
###end p 17
###begin p 18
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 351 352 351 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 405 410 405 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 590 595 590 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 600 605 600 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 613 619 613 619 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 677 682 677 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 619 792 619 792 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="19">DGGE analysis of fragments 11.15&#160;g, 11.4 and 11.10 of the <italic>BRCA2</italic> gene in ten unrelated breast cancer patients. The arrows show altered band mobility compare to other patients</p>
###xml 619 792 619 792 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="19">DGGE analysis of fragments 11.15&#160;g, 11.4 and 11.10 of the <italic>BRCA2</italic> gene in ten unrelated breast cancer patients. The arrows show altered band mobility compare to other patients</p></caption>
###xml 792 792 792 792 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10549_2006_9493_Fig1_HTML" id="MO1"/>
###xml 613 792 613 792 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="19">DGGE analysis of fragments 11.15&#160;g, 11.4 and 11.10 of the <italic>BRCA2</italic> gene in ten unrelated breast cancer patients. The arrows show altered band mobility compare to other patients</p></caption><graphic position="anchor" xlink:href="10549_2006_9493_Fig1_HTML" id="MO1"/></fig>
###xml 792 798 792 798 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 856 857 856 857 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 869 874 869 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 897 898 897 898 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 798 970 798 970 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="20">Sequence electropherogram of a normal individual showing (<bold>A</bold>) wild-type <italic>BRCA2</italic> exon 11 sequence and (<bold>B</bold>) of breast cancer patient (B-3-5) showing c.2699_2704delTAAATG mutation</p>
###xml 798 970 798 970 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="20">Sequence electropherogram of a normal individual showing (<bold>A</bold>) wild-type <italic>BRCA2</italic> exon 11 sequence and (<bold>B</bold>) of breast cancer patient (B-3-5) showing c.2699_2704delTAAATG mutation</p></caption>
###xml 970 970 970 970 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10549_2006_9493_Fig2_HTML" id="MO2"/>
###xml 792 970 792 970 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="20">Sequence electropherogram of a normal individual showing (<bold>A</bold>) wild-type <italic>BRCA2</italic> exon 11 sequence and (<bold>B</bold>) of breast cancer patient (B-3-5) showing c.2699_2704delTAAATG mutation</p></caption><graphic position="anchor" xlink:href="10549_2006_9493_Fig2_HTML" id="MO2"/></fig>
###xml 970 976 970 976 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 993 998 993 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 976 1258 976 1258 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="21">MLPA analysis of <italic>BRCA1</italic> gene of patient sample (blue) compare to the normal control (red). X and Y axis represent peak size and peak height respectively. There are reduced peaks in the patient sample compared to the normal control in exons 13, 14 and 15 (arrows) indicating deletions</p>
###xml 976 1258 976 1258 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="21">MLPA analysis of <italic>BRCA1</italic> gene of patient sample (blue) compare to the normal control (red). X and Y axis represent peak size and peak height respectively. There are reduced peaks in the patient sample compared to the normal control in exons 13, 14 and 15 (arrows) indicating deletions</p></caption>
###xml 1258 1258 1258 1258 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10549_2006_9493_Fig3_HTML" id="MO3"/>
###xml 970 1258 970 1258 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="21">MLPA analysis of <italic>BRCA1</italic> gene of patient sample (blue) compare to the normal control (red). X and Y axis represent peak size and peak height respectively. There are reduced peaks in the patient sample compared to the normal control in exons 13, 14 and 15 (arrows) indicating deletions</p></caption><graphic position="anchor" xlink:href="10549_2006_9493_Fig3_HTML" id="MO3"/></fig>
###xml 98 105 <span type="species:ncbi:9606">persons</span>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
###xml 382 387 <span type="species:ncbi:9606">women</span>
###xml 457 465 <span type="species:ncbi:9606">patients</span>
###xml 719 727 <span type="species:ncbi:9606">patients</span>
###xml 917 924 <span type="species:ncbi:9606">patient</span>
###xml 1007 1014 <span type="species:ncbi:9606">patient</span>
###xml 1160 1167 <span type="species:ncbi:9606">patient</span>
The entire coding regions and exon-intron junctions of BRCA1 and BRCA2 were screened in these 136 persons of breast cancer patients and their families using PCR-DGGE (Fig. 1) followed by sequencing (Fig. 2) for samples with aberrant migrating bands. To optimize the screening, MLPA, a relatively new technique, was also performed in all samples (Fig. 3). Here, we report on 116/120 women (96.7%) for whom BRCA1/2 analysis were completed. The remaining four patients (all from group A) had to be excluded due to the small amount of extracted DNA that did not allow complete screening of the BRCA1 and BRCA2 genes. Fig. 1DGGE analysis of fragments 11.15 g, 11.4 and 11.10 of the BRCA2 gene in ten unrelated breast cancer patients. The arrows show altered band mobility compare to other patientsFig. 2Sequence electropherogram of a normal individual showing (A) wild-type BRCA2 exon 11 sequence and (B) of breast cancer patient (B-3-5) showing c.2699_2704delTAAATG mutationFig. 3MLPA analysis of BRCA1 gene of patient sample (blue) compare to the normal control (red). X and Y axis represent peak size and peak height respectively. There are reduced peaks in the patient sample compared to the normal control in exons 13, 14 and 15 (arrows) indicating deletions
###end p 18
###begin p 19
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
DGGE analysis of fragments 11.15 g, 11.4 and 11.10 of the BRCA2 gene in ten unrelated breast cancer patients. The arrows show altered band mobility compare to other patients
###end p 19
###begin p 20
###xml 58 59 58 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 99 100 99 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 119 126 <span type="species:ncbi:9606">patient</span>
Sequence electropherogram of a normal individual showing (A) wild-type BRCA2 exon 11 sequence and (B) of breast cancer patient (B-3-5) showing c.2699_2704delTAAATG mutation
###end p 20
###begin p 21
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 31 38 <span type="species:ncbi:9606">patient</span>
###xml 184 191 <span type="species:ncbi:9606">patient</span>
MLPA analysis of BRCA1 gene of patient sample (blue) compare to the normal control (red). X and Y axis represent peak size and peak height respectively. There are reduced peaks in the patient sample compared to the normal control in exons 13, 14 and 15 (arrows) indicating deletions
###end p 21
###begin title 22
BRCA1 and BRCA2 pathogenic mutations
###end title 22
###begin p 23
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 217 222 217 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 300 305 300 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 344 345 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 442 443 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 783 790 783 790 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 790 795 790 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 799 804 799 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 790 874 790 874 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="24"><italic>BRCA1</italic> or <italic>BRCA2</italic> germline mutations in Indonesian women with early onset breast cancer</p>
###xml 790 874 790 874 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="24"><italic>BRCA1</italic> or <italic>BRCA2</italic> germline mutations in Indonesian women with early onset breast cancer</p></caption>
###xml 874 881 874 881 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Patient</th>
###xml 884 885 884 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 881 885 881 885 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Age<sup>a</sup></th>
###xml 885 889 885 889 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">gene</th>
###xml 889 893 889 893 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Exon</th>
###xml 901 902 901 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 893 902 893 902 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Mutation<sup>b</sup></th>
###xml 902 915 902 915 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">mutation type</th>
###xml 915 934 915 934 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Pathogenic mutation</th>
###xml 937 938 937 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 934 938 934 938 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">BIC<sup>c</sup></th>
###xml 874 938 874 938 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Patient</th><th align="left">Age<sup>a</sup></th><th align="left">gene</th><th align="left">Exon</th><th align="left">Mutation<sup>b</sup></th><th align="left">mutation type</th><th align="left">Pathogenic mutation</th><th align="left">BIC<sup>c</sup></th></tr>
###xml 874 938 874 938 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Patient</th><th align="left">Age<sup>a</sup></th><th align="left">gene</th><th align="left">Exon</th><th align="left">Mutation<sup>b</sup></th><th align="left">mutation type</th><th align="left">Pathogenic mutation</th><th align="left">BIC<sup>c</sup></th></tr></thead>
###xml 938 940 938 940 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">AE</td>
###xml 940 942 940 942 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">25</td>
###xml 942 947 942 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 942 947 942 947 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA1</italic></td>
###xml 947 949 947 949 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11</td>
###xml 949 964 949 964 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">c.2784_2785insT</td>
###xml 964 974 964 974 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">frameshift</td>
###xml 974 975 974 975 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">+</td>
###xml 975 977 975 977 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">no</td>
###xml 938 977 938 977 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">AE</td><td char="." align="char">25</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">11</td><td char="." align="char">c.2784_2785insT</td><td char="." align="char">frameshift</td><td char="." align="char">+</td><td char="." align="char">no</td></tr>
###xml 977 980 977 980 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">B10</td>
###xml 980 982 980 982 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">31</td>
###xml 982 987 982 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 982 987 982 987 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA1</italic></td>
###xml 987 989 987 989 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">13</td>
###xml 989 999 989 999 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Leu1415X</td>
###xml 999 1007 999 1007 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">nonsense</td>
###xml 1007 1008 1007 1008 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">+</td>
###xml 1008 1010 1008 1010 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">no</td>
###xml 977 1010 977 1010 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">B10</td><td char="." align="char">31</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">13</td><td char="." align="char">p.Leu1415X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr>
###xml 1010 1012 1010 1012 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">AA</td>
###xml 1012 1014 1012 1014 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">40</td>
###xml 1014 1019 1014 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 1014 1019 1014 1019 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA1</italic></td>
###xml 1019 1024 1019 1024 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">13&#8211;15</td>
###xml 1025 1026 1025 1026 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 1024 1026 1024 1026 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;<sup>d</sup></td>
###xml 1026 1045 1026 1045 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">large rearrangement</td>
###xml 1045 1046 1045 1046 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">+</td>
###xml 1046 1048 1046 1048 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">no</td>
###xml 1010 1048 1010 1048 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">AA</td><td char="." align="char">40</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">13&#8211;15</td><td char="." align="char">&#8722;<sup>d</sup></td><td char="." align="char">large rearrangement</td><td char="." align="char">+</td><td char="." align="char">no</td></tr>
###xml 1048 1050 1048 1050 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">AB</td>
###xml 1050 1052 1050 1052 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">34</td>
###xml 1052 1057 1052 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1052 1057 1052 1057 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1057 1059 1057 1059 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11</td>
###xml 1059 1074 1059 1074 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">c.3040_3043del4</td>
###xml 1074 1084 1074 1084 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">frameshift</td>
###xml 1084 1085 1084 1085 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">+</td>
###xml 1085 1086 1085 1086 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1</td>
###xml 1048 1086 1048 1086 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">AB</td><td char="." align="char">34</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">c.3040_3043del4</td><td char="." align="char">frameshift</td><td char="." align="char">+</td><td char="." align="char">1</td></tr>
###xml 1086 1088 1086 1088 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">B5</td>
###xml 1088 1090 1088 1090 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">66</td>
###xml 1090 1095 1090 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1090 1095 1090 1095 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1095 1097 1095 1097 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11</td>
###xml 1097 1107 1097 1107 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Glu2183X</td>
###xml 1107 1115 1107 1115 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">nonsense</td>
###xml 1115 1116 1115 1116 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">+</td>
###xml 1116 1118 1116 1118 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">no</td>
###xml 1086 1118 1086 1118 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">B5</td><td char="." align="char">66</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Glu2183X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr>
###xml 1118 1120 1118 1120 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">B6</td>
###xml 1120 1122 1120 1122 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">65</td>
###xml 1122 1127 1122 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1122 1127 1122 1127 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1127 1129 1127 1129 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11</td>
###xml 1129 1139 1129 1139 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Glu2183X</td>
###xml 1139 1147 1139 1147 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">nonsense</td>
###xml 1147 1148 1147 1148 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">+</td>
###xml 1148 1150 1148 1150 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">no</td>
###xml 1118 1150 1118 1150 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">B6</td><td char="." align="char">65</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Glu2183X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr>
###xml 1150 1157 1150 1157 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">B-III-5</td>
###xml 1157 1159 1157 1159 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">30</td>
###xml 1159 1164 1159 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1159 1164 1159 1164 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1164 1166 1164 1166 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11</td>
###xml 1166 1175 1166 1175 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Leu824X</td>
###xml 1175 1183 1175 1183 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">nonsense</td>
###xml 1183 1184 1183 1184 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">+</td>
###xml 1184 1186 1184 1186 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">no</td>
###xml 1150 1186 1150 1186 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">B-III-5</td><td char="." align="char">30</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Leu824X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr>
###xml 1186 1188 1186 1188 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">AZ</td>
###xml 1188 1190 1188 1190 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">40</td>
###xml 1190 1195 1190 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1190 1195 1190 1195 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1195 1197 1195 1197 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11</td>
###xml 1197 1206 1197 1206 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Leu824X</td>
###xml 1206 1214 1206 1214 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">nonsense</td>
###xml 1214 1215 1214 1215 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">+</td>
###xml 1215 1217 1215 1217 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">no</td>
###xml 1186 1217 1186 1217 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">AZ</td><td char="." align="char">40</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Leu824X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr>
###xml 1217 1221 1217 1221 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">W-II</td>
###xml 1221 1223 1221 1223 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">37</td>
###xml 1223 1228 1223 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1223 1228 1223 1228 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1228 1230 1228 1230 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">21</td>
###xml 1230 1240 1230 1240 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Gln2894X</td>
###xml 1240 1248 1240 1248 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">nonsense</td>
###xml 1248 1249 1248 1249 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">+</td>
###xml 1249 1251 1249 1251 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">no</td>
###xml 1217 1251 1217 1251 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">W-II</td><td char="." align="char">37</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">21</td><td char="." align="char">p.Gln2894X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr>
###xml 1251 1255 1251 1255 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Q-II</td>
###xml 1255 1257 1255 1257 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">40</td>
###xml 1257 1262 1257 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 1257 1262 1257 1262 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA1</italic></td>
###xml 1262 1263 1262 1263 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2</td>
###xml 1263 1274 1263 1274 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">c.101&#8211;10T&gt;C</td>
###xml 1274 1277 1274 1277 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">IVS</td>
###xml 1277 1280 1277 1278 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#177;</td>
###xml 1280 1281 1278 1279 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6</td>
###xml 1251 1281 1251 1279 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">Q-II</td><td char="." align="char">40</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">2</td><td char="." align="char">c.101&#8211;10T&gt;C</td><td char="." align="char">IVS</td><td char="." align="char">&#177;</td><td char="." align="char">6</td></tr>
###xml 1281 1289 1279 1287 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">P-III-19</td>
###xml 1289 1291 1287 1289 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">19</td>
###xml 1291 1296 1289 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 1291 1296 1289 1294 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA1</italic></td>
###xml 1296 1297 1294 1295 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">9</td>
###xml 1297 1308 1295 1306 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Val191Ile</td>
###xml 1308 1316 1306 1314 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Missense</td>
###xml 1316 1319 1314 1315 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#177;</td>
###xml 1319 1320 1315 1316 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6</td>
###xml 1281 1320 1279 1316 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">P-III-19</td><td char="." align="char">19</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">9</td><td char="." align="char">p.Val191Ile</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">6</td></tr>
###xml 1320 1323 1316 1319 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">J22</td>
###xml 1323 1325 1319 1321 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">32</td>
###xml 1325 1330 1321 1326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 1325 1330 1321 1326 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA1</italic></td>
###xml 1330 1332 1326 1328 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11</td>
###xml 1332 1344 1328 1340 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Leu1209Val</td>
###xml 1344 1352 1340 1348 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Missense</td>
###xml 1352 1353 1348 1349 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">?</td>
###xml 1353 1355 1349 1351 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">no</td>
###xml 1320 1355 1316 1351 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">J22</td><td char="." align="char">32</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">11</td><td char="." align="char">p.Leu1209Val</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr>
###xml 1355 1357 1351 1353 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">AZ</td>
###xml 1357 1359 1353 1355 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">40</td>
###xml 1359 1364 1355 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 1359 1364 1355 1360 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA1</italic></td>
###xml 1364 1366 1360 1362 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">16</td>
###xml 1366 1378 1362 1374 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Met1652Ile</td>
###xml 1378 1386 1374 1382 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Missense</td>
###xml 1386 1389 1382 1383 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#177;</td>
###xml 1389 1391 1383 1385 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">35</td>
###xml 1355 1391 1351 1385 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">AZ</td><td char="." align="char">40</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">16</td><td char="." align="char">p.Met1652Ile</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">35</td></tr>
###xml 1391 1394 1385 1388 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">B1 </td>
###xml 1394 1396 1388 1390 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">24</td>
###xml 1396 1401 1390 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 1396 1401 1390 1395 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA1</italic></td>
###xml 1401 1403 1395 1397 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">20</td>
###xml 1403 1415 1397 1409 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">c.5313&#8211;31A&gt;G</td>
###xml 1415 1418 1409 1412 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">IVS</td>
###xml 1418 1419 1412 1413 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">?</td>
###xml 1419 1421 1413 1415 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">no</td>
###xml 1391 1421 1385 1415 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">B1 </td><td char="." align="char">24</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">20</td><td char="." align="char">c.5313&#8211;31A&gt;G</td><td char="." align="char">IVS</td><td char="." align="char">?</td><td char="." align="char">no</td></tr>
###xml 1421 1423 1415 1417 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">B7</td>
###xml 1423 1425 1417 1419 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">31</td>
###xml 1425 1430 1419 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 1425 1430 1419 1424 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA1</italic></td>
###xml 1430 1432 1424 1426 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">24</td>
###xml 1432 1444 1426 1438 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Arg1835Gln</td>
###xml 1444 1452 1438 1446 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Missense</td>
###xml 1452 1453 1446 1447 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">?</td>
###xml 1453 1455 1447 1449 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">no</td>
###xml 1421 1455 1415 1449 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">B7</td><td char="." align="char">31</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">24</td><td char="." align="char">p.Arg1835Gln</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr>
###xml 1455 1458 1449 1452 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">216</td>
###xml 1458 1460 1452 1454 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">33</td>
###xml 1460 1465 1454 1459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 1460 1465 1454 1459 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA1</italic></td>
###xml 1465 1467 1459 1461 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">24</td>
###xml 1467 1479 1461 1473 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Thr1852Ile</td>
###xml 1479 1487 1473 1481 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Missense</td>
###xml 1487 1488 1481 1482 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">?</td>
###xml 1488 1490 1482 1484 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">no</td>
###xml 1455 1490 1449 1484 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">216</td><td char="." align="char">33</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">24</td><td char="." align="char">p.Thr1852Ile</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr>
###xml 1490 1498 1484 1492 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">P-III-19</td>
###xml 1498 1500 1492 1494 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">19</td>
###xml 1500 1505 1494 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1500 1505 1494 1499 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1505 1506 1499 1500 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5</td>
###xml 1506 1517 1500 1511 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Gln147Arg</td>
###xml 1517 1525 1511 1519 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Missense</td>
###xml 1525 1528 1519 1520 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#177;</td>
###xml 1528 1529 1520 1521 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6</td>
###xml 1490 1529 1484 1521 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">P-III-19</td><td char="." align="char">19</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">5</td><td char="." align="char">p.Gln147Arg</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">6</td></tr>
###xml 1529 1531 1521 1523 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">B3</td>
###xml 1531 1533 1523 1525 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">24</td>
###xml 1533 1538 1525 1530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1533 1538 1525 1530 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1538 1540 1530 1532 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">10</td>
###xml 1540 1551 1532 1543 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Gln609Glu</td>
###xml 1551 1559 1543 1551 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Missense</td>
###xml 1559 1560 1551 1552 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">?</td>
###xml 1560 1562 1552 1554 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">no</td>
###xml 1529 1562 1521 1554 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">B3</td><td char="." align="char">24</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">10</td><td char="." align="char">p.Gln609Glu</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr>
###xml 1562 1568 1554 1560 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">C-II-7</td>
###xml 1568 1570 1560 1562 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">39</td>
###xml 1570 1575 1562 1567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1570 1575 1562 1567 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1575 1577 1567 1569 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11</td>
###xml 1577 1589 1569 1581 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Met1149Val</td>
###xml 1589 1597 1581 1589 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Missense</td>
###xml 1597 1600 1589 1590 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#177;</td>
###xml 1600 1601 1590 1591 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5</td>
###xml 1562 1601 1554 1591 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">C-II-7</td><td char="." align="char">39</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Met1149Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">5</td></tr>
###xml 1601 1603 1591 1593 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">AO</td>
###xml 1603 1605 1593 1595 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">28</td>
###xml 1605 1610 1595 1600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1605 1610 1595 1600 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1610 1612 1600 1602 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11</td>
###xml 1612 1624 1602 1614 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Met1149Val</td>
###xml 1624 1632 1614 1622 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Missense</td>
###xml 1632 1635 1622 1623 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#177;</td>
###xml 1635 1636 1623 1624 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5</td>
###xml 1601 1636 1591 1624 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">AO</td><td char="." align="char">28</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Met1149Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">5</td></tr>
###xml 1636 1638 1624 1626 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">AQ</td>
###xml 1638 1640 1626 1628 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">44</td>
###xml 1640 1645 1628 1633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1640 1645 1628 1633 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1645 1647 1633 1635 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11</td>
###xml 1647 1659 1635 1647 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Met1149Val</td>
###xml 1659 1667 1647 1655 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Missense</td>
###xml 1667 1670 1655 1656 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#177;</td>
###xml 1670 1671 1656 1657 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5</td>
###xml 1636 1671 1624 1657 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">AQ</td><td char="." align="char">44</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Met1149Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">5</td></tr>
###xml 1671 1673 1657 1659 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">BH</td>
###xml 1673 1675 1659 1661 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">38</td>
###xml 1675 1680 1661 1666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1675 1680 1661 1666 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1680 1682 1666 1668 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11</td>
###xml 1682 1694 1668 1680 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Met1149Val</td>
###xml 1694 1702 1680 1688 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Missense</td>
###xml 1702 1705 1688 1689 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#177;</td>
###xml 1705 1706 1689 1690 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5</td>
###xml 1671 1706 1657 1690 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">BH</td><td char="." align="char">38</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Met1149Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">5</td></tr>
###xml 1706 1709 1690 1693 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">172</td>
###xml 1709 1711 1693 1695 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">36</td>
###xml 1711 1716 1695 1700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1711 1716 1695 1700 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1716 1718 1700 1702 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11</td>
###xml 1718 1729 1702 1713 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Gln699Leu</td>
###xml 1729 1737 1713 1721 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Missense</td>
###xml 1737 1738 1721 1722 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">?</td>
###xml 1738 1740 1722 1724 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">no</td>
###xml 1706 1740 1690 1724 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">172</td><td char="." align="char">36</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Gln699Leu</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr>
###xml 1740 1743 1724 1727 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">J32</td>
###xml 1743 1745 1727 1729 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">29</td>
###xml 1745 1750 1729 1734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1745 1750 1729 1734 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1750 1752 1734 1736 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11</td>
###xml 1752 1764 1736 1748 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Arg2108Cys</td>
###xml 1764 1772 1748 1756 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Missense</td>
###xml 1772 1775 1756 1757 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#177;</td>
###xml 1775 1777 1757 1759 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">16</td>
###xml 1740 1777 1724 1759 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">J32</td><td char="." align="char">29</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Arg2108Cys</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">16</td></tr>
###xml 1777 1779 1759 1761 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">J6</td>
###xml 1779 1781 1761 1763 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">33</td>
###xml 1781 1786 1763 1768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1781 1786 1763 1768 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1786 1788 1768 1770 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11</td>
###xml 1788 1799 1770 1781 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Val950Ile</td>
###xml 1799 1807 1781 1789 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Missense</td>
###xml 1807 1808 1789 1790 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">?</td>
###xml 1808 1810 1790 1792 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">no</td>
###xml 1777 1810 1759 1792 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">J6</td><td char="." align="char">33</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Val950Ile</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr>
###xml 1810 1813 1792 1795 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">206</td>
###xml 1813 1815 1795 1797 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">37</td>
###xml 1815 1820 1797 1802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1815 1820 1797 1802 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1820 1822 1802 1804 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">25</td>
###xml 1822 1834 1804 1816 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">c.9485&#8211;16T&gt;C</td>
###xml 1834 1837 1816 1819 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">IVS</td>
###xml 1837 1840 1819 1820 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#177;</td>
###xml 1840 1841 1820 1821 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4</td>
###xml 1810 1841 1792 1821 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">206</td><td char="." align="char">37</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">25</td><td char="." align="char">c.9485&#8211;16T&gt;C</td><td char="." align="char">IVS</td><td char="." align="char">&#177;</td><td char="." align="char">4</td></tr>
###xml 1841 1843 1821 1823 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">BC</td>
###xml 1843 1845 1823 1825 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">35</td>
###xml 1845 1850 1825 1830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1845 1850 1825 1830 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1850 1852 1830 1832 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">27</td>
###xml 1852 1864 1832 1844 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Ile3412Val</td>
###xml 1864 1872 1844 1852 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Missense</td>
###xml 1872 1875 1852 1853 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#177;</td>
###xml 1875 1878 1853 1856 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">109</td>
###xml 1841 1878 1821 1856 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">BC</td><td char="." align="char">35</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">27</td><td char="." align="char">p.Ile3412Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">109</td></tr>
###xml 1878 1881 1856 1859 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">166</td>
###xml 1881 1883 1859 1861 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">33</td>
###xml 1883 1888 1861 1866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1883 1888 1861 1866 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1888 1890 1866 1868 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">27</td>
###xml 1890 1902 1868 1880 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Ile3412Val</td>
###xml 1902 1910 1880 1888 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Missense</td>
###xml 1910 1913 1888 1889 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#177;</td>
###xml 1913 1916 1889 1892 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">109</td>
###xml 1878 1916 1856 1892 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">166</td><td char="." align="char">33</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">27</td><td char="." align="char">p.Ile3412Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">109</td></tr>
###xml 1916 1919 1892 1895 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">J24</td>
###xml 1919 1921 1895 1897 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">35</td>
###xml 1921 1926 1897 1902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1921 1926 1897 1902 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1926 1928 1902 1904 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">27</td>
###xml 1928 1940 1904 1916 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Ile3412Val</td>
###xml 1940 1948 1916 1924 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Missense</td>
###xml 1948 1951 1924 1925 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#177;</td>
###xml 1951 1954 1925 1928 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">109</td>
###xml 1916 1954 1892 1928 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">J24</td><td char="." align="char">35</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">27</td><td char="." align="char">p.Ile3412Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">109</td></tr>
###xml 1954 1957 1928 1931 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">206</td>
###xml 1957 1959 1931 1933 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">37</td>
###xml 1959 1964 1933 1938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1959 1964 1933 1938 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"><italic>BRCA2</italic></td>
###xml 1964 1966 1938 1940 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">27</td>
###xml 1966 1976 1940 1950 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">p.Lys3326X</td>
###xml 1976 1985 1950 1959 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">nonsense </td>
###xml 1985 1988 1959 1960 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#177;</td>
###xml 1988 1991 1960 1963 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">289</td>
###xml 1954 1991 1928 1963 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">206</td><td char="." align="char">37</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">27</td><td char="." align="char">p.Lys3326X</td><td char="." align="char">nonsense </td><td char="." align="char">&#177;</td><td char="." align="char">289</td></tr>
###xml 938 1991 938 1963 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td char="." align="char">AE</td><td char="." align="char">25</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">11</td><td char="." align="char">c.2784_2785insT</td><td char="." align="char">frameshift</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">B10</td><td char="." align="char">31</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">13</td><td char="." align="char">p.Leu1415X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">AA</td><td char="." align="char">40</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">13&#8211;15</td><td char="." align="char">&#8722;<sup>d</sup></td><td char="." align="char">large rearrangement</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">AB</td><td char="." align="char">34</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">c.3040_3043del4</td><td char="." align="char">frameshift</td><td char="." align="char">+</td><td char="." align="char">1</td></tr><tr><td char="." align="char">B5</td><td char="." align="char">66</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Glu2183X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">B6</td><td char="." align="char">65</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Glu2183X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">B-III-5</td><td char="." align="char">30</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Leu824X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">AZ</td><td char="." align="char">40</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Leu824X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">W-II</td><td char="." align="char">37</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">21</td><td char="." align="char">p.Gln2894X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">Q-II</td><td char="." align="char">40</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">2</td><td char="." align="char">c.101&#8211;10T&gt;C</td><td char="." align="char">IVS</td><td char="." align="char">&#177;</td><td char="." align="char">6</td></tr><tr><td char="." align="char">P-III-19</td><td char="." align="char">19</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">9</td><td char="." align="char">p.Val191Ile</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">6</td></tr><tr><td char="." align="char">J22</td><td char="." align="char">32</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">11</td><td char="." align="char">p.Leu1209Val</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">AZ</td><td char="." align="char">40</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">16</td><td char="." align="char">p.Met1652Ile</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">35</td></tr><tr><td char="." align="char">B1 </td><td char="." align="char">24</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">20</td><td char="." align="char">c.5313&#8211;31A&gt;G</td><td char="." align="char">IVS</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">B7</td><td char="." align="char">31</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">24</td><td char="." align="char">p.Arg1835Gln</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">216</td><td char="." align="char">33</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">24</td><td char="." align="char">p.Thr1852Ile</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">P-III-19</td><td char="." align="char">19</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">5</td><td char="." align="char">p.Gln147Arg</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">6</td></tr><tr><td char="." align="char">B3</td><td char="." align="char">24</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">10</td><td char="." align="char">p.Gln609Glu</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">C-II-7</td><td char="." align="char">39</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Met1149Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">5</td></tr><tr><td char="." align="char">AO</td><td char="." align="char">28</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Met1149Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">5</td></tr><tr><td char="." align="char">AQ</td><td char="." align="char">44</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Met1149Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">5</td></tr><tr><td char="." align="char">BH</td><td char="." align="char">38</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Met1149Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">5</td></tr><tr><td char="." align="char">172</td><td char="." align="char">36</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Gln699Leu</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">J32</td><td char="." align="char">29</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Arg2108Cys</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">16</td></tr><tr><td char="." align="char">J6</td><td char="." align="char">33</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Val950Ile</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">206</td><td char="." align="char">37</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">25</td><td char="." align="char">c.9485&#8211;16T&gt;C</td><td char="." align="char">IVS</td><td char="." align="char">&#177;</td><td char="." align="char">4</td></tr><tr><td char="." align="char">BC</td><td char="." align="char">35</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">27</td><td char="." align="char">p.Ile3412Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">109</td></tr><tr><td char="." align="char">166</td><td char="." align="char">33</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">27</td><td char="." align="char">p.Ile3412Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">109</td></tr><tr><td char="." align="char">J24</td><td char="." align="char">35</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">27</td><td char="." align="char">p.Ile3412Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">109</td></tr><tr><td char="." align="char">206</td><td char="." align="char">37</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">27</td><td char="." align="char">p.Lys3326X</td><td char="." align="char">nonsense </td><td char="." align="char">&#177;</td><td char="." align="char">289</td></tr></tbody>
###xml 874 1991 874 1963 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Patient</th><th align="left">Age<sup>a</sup></th><th align="left">gene</th><th align="left">Exon</th><th align="left">Mutation<sup>b</sup></th><th align="left">mutation type</th><th align="left">Pathogenic mutation</th><th align="left">BIC<sup>c</sup></th></tr></thead><tbody><tr><td char="." align="char">AE</td><td char="." align="char">25</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">11</td><td char="." align="char">c.2784_2785insT</td><td char="." align="char">frameshift</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">B10</td><td char="." align="char">31</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">13</td><td char="." align="char">p.Leu1415X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">AA</td><td char="." align="char">40</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">13&#8211;15</td><td char="." align="char">&#8722;<sup>d</sup></td><td char="." align="char">large rearrangement</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">AB</td><td char="." align="char">34</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">c.3040_3043del4</td><td char="." align="char">frameshift</td><td char="." align="char">+</td><td char="." align="char">1</td></tr><tr><td char="." align="char">B5</td><td char="." align="char">66</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Glu2183X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">B6</td><td char="." align="char">65</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Glu2183X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">B-III-5</td><td char="." align="char">30</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Leu824X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">AZ</td><td char="." align="char">40</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Leu824X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">W-II</td><td char="." align="char">37</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">21</td><td char="." align="char">p.Gln2894X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">Q-II</td><td char="." align="char">40</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">2</td><td char="." align="char">c.101&#8211;10T&gt;C</td><td char="." align="char">IVS</td><td char="." align="char">&#177;</td><td char="." align="char">6</td></tr><tr><td char="." align="char">P-III-19</td><td char="." align="char">19</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">9</td><td char="." align="char">p.Val191Ile</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">6</td></tr><tr><td char="." align="char">J22</td><td char="." align="char">32</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">11</td><td char="." align="char">p.Leu1209Val</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">AZ</td><td char="." align="char">40</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">16</td><td char="." align="char">p.Met1652Ile</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">35</td></tr><tr><td char="." align="char">B1 </td><td char="." align="char">24</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">20</td><td char="." align="char">c.5313&#8211;31A&gt;G</td><td char="." align="char">IVS</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">B7</td><td char="." align="char">31</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">24</td><td char="." align="char">p.Arg1835Gln</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">216</td><td char="." align="char">33</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">24</td><td char="." align="char">p.Thr1852Ile</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">P-III-19</td><td char="." align="char">19</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">5</td><td char="." align="char">p.Gln147Arg</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">6</td></tr><tr><td char="." align="char">B3</td><td char="." align="char">24</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">10</td><td char="." align="char">p.Gln609Glu</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">C-II-7</td><td char="." align="char">39</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Met1149Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">5</td></tr><tr><td char="." align="char">AO</td><td char="." align="char">28</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Met1149Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">5</td></tr><tr><td char="." align="char">AQ</td><td char="." align="char">44</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Met1149Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">5</td></tr><tr><td char="." align="char">BH</td><td char="." align="char">38</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Met1149Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">5</td></tr><tr><td char="." align="char">172</td><td char="." align="char">36</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Gln699Leu</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">J32</td><td char="." align="char">29</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Arg2108Cys</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">16</td></tr><tr><td char="." align="char">J6</td><td char="." align="char">33</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Val950Ile</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">206</td><td char="." align="char">37</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">25</td><td char="." align="char">c.9485&#8211;16T&gt;C</td><td char="." align="char">IVS</td><td char="." align="char">&#177;</td><td char="." align="char">4</td></tr><tr><td char="." align="char">BC</td><td char="." align="char">35</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">27</td><td char="." align="char">p.Ile3412Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">109</td></tr><tr><td char="." align="char">166</td><td char="." align="char">33</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">27</td><td char="." align="char">p.Ile3412Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">109</td></tr><tr><td char="." align="char">J24</td><td char="." align="char">35</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">27</td><td char="." align="char">p.Ile3412Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">109</td></tr><tr><td char="." align="char">206</td><td char="." align="char">37</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">27</td><td char="." align="char">p.Lys3326X</td><td char="." align="char">nonsense </td><td char="." align="char">&#177;</td><td char="." align="char">289</td></tr></tbody></table>
###xml 1991 1992 1963 1964 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1991 2016 1963 1988 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="25"><sup>a</sup>Age at time of diagnosis</p>
###xml 2016 2017 1988 1989 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2044 2049 2016 2021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 2059 2064 2031 2036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 2016 2072 1988 2044 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="26"><sup>b</sup>Gen Bank Accession number, <italic>BRCA1</italic>: U14680, <italic>BRCA2</italic>: U43746</p>
###xml 2072 2073 2044 2045 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 2072 2104 2044 2076 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="27"><sup>c</sup>number of times reported in BIC</p>
###xml 2104 2105 2076 2077 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 2104 2137 2076 2109 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28"><sup>d</sup>not determined, detected by MLPA</p>
###xml 1991 2137 1963 2109 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="25"><sup>a</sup>Age at time of diagnosis</p><p textid="26"><sup>b</sup>Gen Bank Accession number, <italic>BRCA1</italic>: U14680, <italic>BRCA2</italic>: U43746</p><p textid="27"><sup>c</sup>number of times reported in BIC</p><p textid="28"><sup>d</sup>not determined, detected by MLPA</p></table-wrap-foot>
###xml 783 2137 783 2109 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="24"><italic>BRCA1</italic> or <italic>BRCA2</italic> germline mutations in Indonesian women with early onset breast cancer</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Patient</th><th align="left">Age<sup>a</sup></th><th align="left">gene</th><th align="left">Exon</th><th align="left">Mutation<sup>b</sup></th><th align="left">mutation type</th><th align="left">Pathogenic mutation</th><th align="left">BIC<sup>c</sup></th></tr></thead><tbody><tr><td char="." align="char">AE</td><td char="." align="char">25</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">11</td><td char="." align="char">c.2784_2785insT</td><td char="." align="char">frameshift</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">B10</td><td char="." align="char">31</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">13</td><td char="." align="char">p.Leu1415X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">AA</td><td char="." align="char">40</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">13&#8211;15</td><td char="." align="char">&#8722;<sup>d</sup></td><td char="." align="char">large rearrangement</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">AB</td><td char="." align="char">34</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">c.3040_3043del4</td><td char="." align="char">frameshift</td><td char="." align="char">+</td><td char="." align="char">1</td></tr><tr><td char="." align="char">B5</td><td char="." align="char">66</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Glu2183X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">B6</td><td char="." align="char">65</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Glu2183X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">B-III-5</td><td char="." align="char">30</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Leu824X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">AZ</td><td char="." align="char">40</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Leu824X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">W-II</td><td char="." align="char">37</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">21</td><td char="." align="char">p.Gln2894X</td><td char="." align="char">nonsense</td><td char="." align="char">+</td><td char="." align="char">no</td></tr><tr><td char="." align="char">Q-II</td><td char="." align="char">40</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">2</td><td char="." align="char">c.101&#8211;10T&gt;C</td><td char="." align="char">IVS</td><td char="." align="char">&#177;</td><td char="." align="char">6</td></tr><tr><td char="." align="char">P-III-19</td><td char="." align="char">19</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">9</td><td char="." align="char">p.Val191Ile</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">6</td></tr><tr><td char="." align="char">J22</td><td char="." align="char">32</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">11</td><td char="." align="char">p.Leu1209Val</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">AZ</td><td char="." align="char">40</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">16</td><td char="." align="char">p.Met1652Ile</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">35</td></tr><tr><td char="." align="char">B1 </td><td char="." align="char">24</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">20</td><td char="." align="char">c.5313&#8211;31A&gt;G</td><td char="." align="char">IVS</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">B7</td><td char="." align="char">31</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">24</td><td char="." align="char">p.Arg1835Gln</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">216</td><td char="." align="char">33</td><td char="." align="char"><italic>BRCA1</italic></td><td char="." align="char">24</td><td char="." align="char">p.Thr1852Ile</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">P-III-19</td><td char="." align="char">19</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">5</td><td char="." align="char">p.Gln147Arg</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">6</td></tr><tr><td char="." align="char">B3</td><td char="." align="char">24</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">10</td><td char="." align="char">p.Gln609Glu</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">C-II-7</td><td char="." align="char">39</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Met1149Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">5</td></tr><tr><td char="." align="char">AO</td><td char="." align="char">28</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Met1149Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">5</td></tr><tr><td char="." align="char">AQ</td><td char="." align="char">44</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Met1149Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">5</td></tr><tr><td char="." align="char">BH</td><td char="." align="char">38</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Met1149Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">5</td></tr><tr><td char="." align="char">172</td><td char="." align="char">36</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Gln699Leu</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">J32</td><td char="." align="char">29</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Arg2108Cys</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">16</td></tr><tr><td char="." align="char">J6</td><td char="." align="char">33</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">11</td><td char="." align="char">p.Val950Ile</td><td char="." align="char">Missense</td><td char="." align="char">?</td><td char="." align="char">no</td></tr><tr><td char="." align="char">206</td><td char="." align="char">37</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">25</td><td char="." align="char">c.9485&#8211;16T&gt;C</td><td char="." align="char">IVS</td><td char="." align="char">&#177;</td><td char="." align="char">4</td></tr><tr><td char="." align="char">BC</td><td char="." align="char">35</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">27</td><td char="." align="char">p.Ile3412Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">109</td></tr><tr><td char="." align="char">166</td><td char="." align="char">33</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">27</td><td char="." align="char">p.Ile3412Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">109</td></tr><tr><td char="." align="char">J24</td><td char="." align="char">35</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">27</td><td char="." align="char">p.Ile3412Val</td><td char="." align="char">Missense</td><td char="." align="char">&#177;</td><td char="." align="char">109</td></tr><tr><td char="." align="char">206</td><td char="." align="char">37</td><td char="." align="char"><italic>BRCA2</italic></td><td char="." align="char">27</td><td char="." align="char">p.Lys3326X</td><td char="." align="char">nonsense </td><td char="." align="char">&#177;</td><td char="." align="char">289</td></tr></tbody></table><table-wrap-foot><p textid="25"><sup>a</sup>Age at time of diagnosis</p><p textid="26"><sup>b</sup>Gen Bank Accession number, <italic>BRCA1</italic>: U14680, <italic>BRCA2</italic>: U43746</p><p textid="27"><sup>c</sup>number of times reported in BIC</p><p textid="28"><sup>d</sup>not determined, detected by MLPA</p></table-wrap-foot></table-wrap>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
###xml 91 99 <span type="species:ncbi:9606">patients</span>
###xml 172 180 <span type="species:ncbi:9606">patients</span>
###xml 838 843 <span type="species:ncbi:9606">women</span>
The analysis of 116 unrelated breast cancer patients with breast cancer revealed that nine patients (7.8%) carried pathogenic germline mutations especially the early onset patients: 3 within BRCA1 (2.6%) and 6 within BRCA2 (5.2%) which is comparable to previous studies [21]. We only found BRCA1 and BRCA2 mutations in groups A ("early onset", n = 7 out of 98, 7.1%) and B (two cases of breast cancer in the same family before the age of 60, n = 2 out of 9 (22.2%)) (Table 1). There were twice as many BRCA2 mutations as BRCA1 mutations. Although the absolute numbers are low and no firm conclusions can therefore be drawn, this is comparable to other Asian regions [22-24] but seems to discern the Indonesian population from non-Asian ethnic groups where the reverse trend is seen. Table 1BRCA1 or BRCA2 germline mutations in Indonesian women with early onset breast cancerPatientAgeageneExonMutationbmutation typePathogenic mutationBICcAE25BRCA111c.2784_2785insTframeshift+noB1031BRCA113p.Leu1415Xnonsense+noAA40BRCA113-15-dlarge rearrangement+noAB34BRCA211c.3040_3043del4frameshift+1B566BRCA211p.Glu2183Xnonsense+noB665BRCA211p.Glu2183Xnonsense+noB-III-530BRCA211p.Leu824Xnonsense+noAZ40BRCA211p.Leu824Xnonsense+noW-II37BRCA221p.Gln2894Xnonsense+noQ-II40BRCA12c.101-10T>CIVS+/-6P-III-1919BRCA19p.Val191IleMissense+/-6J2232BRCA111p.Leu1209ValMissense?noAZ40BRCA116p.Met1652IleMissense+/-35B1 24BRCA120c.5313-31A>GIVS?noB731BRCA124p.Arg1835GlnMissense?no21633BRCA124p.Thr1852IleMissense?noP-III-1919BRCA25p.Gln147ArgMissense+/-6B324BRCA210p.Gln609GluMissense?noC-II-739BRCA211p.Met1149ValMissense+/-5AO28BRCA211p.Met1149ValMissense+/-5AQ44BRCA211p.Met1149ValMissense+/-5BH38BRCA211p.Met1149ValMissense+/-517236BRCA211p.Gln699LeuMissense?noJ3229BRCA211p.Arg2108CysMissense+/-16J633BRCA211p.Val950IleMissense?no20637BRCA225c.9485-16T>CIVS+/-4BC35BRCA227p.Ile3412ValMissense+/-10916633BRCA227p.Ile3412ValMissense+/-109J2435BRCA227p.Ile3412ValMissense+/-10920637BRCA227p.Lys3326Xnonsense +/-289aAge at time of diagnosisbGen Bank Accession number, BRCA1: U14680, BRCA2: U43746cnumber of times reported in BICdnot determined, detected by MLPA
###end p 23
###begin p 24
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 48 53 <span type="species:ncbi:9606">women</span>
BRCA1 or BRCA2 germline mutations in Indonesian women with early onset breast cancer
###end p 24
###begin p 25
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aAge at time of diagnosis
###end p 25
###begin p 26
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
bGen Bank Accession number, BRCA1: U14680, BRCA2: U43746
###end p 26
###begin p 27
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
cnumber of times reported in BIC
###end p 27
###begin p 28
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
dnot determined, detected by MLPA
###end p 28
###begin p 29
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 144 149 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 399 404 399 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 536 541 536 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 590 598 <span type="species:ncbi:9606">patients</span>
Seven pathogenic mutations were found in nine probands: three in BRCA1 (c.2784_2785insT, pL1415X (c.4361_4362insT), del exon 13-15) and four in BRCA2 (c.3040_3043delGCAA, p.Glu2183X (c.6775G>T), p.Leu824X (c.2699_2704delTAAATG), p.Gln2894X (c.9008C>T)). All these mutations were classified as pathogenic as they are predicted to result in protein truncation. The three pathogenic mutations found in BRCA1 were not previously reported in the BIC database as well as two novel nonsense mutations (p.Glu2183X and p.Gln2894X) identified in BRCA2. The p.Glu2183X mutation was found in 2 related patients that had breast cancer above the age of 60.
###end p 29
###begin p 30
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 451 456 451 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 671 676 671 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 969 976 969 976 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 1059 1064 1059 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 1068 1073 1068 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 976 1092 976 1092 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="31">Clinicopathological features of Indonesian breast cancer patients with deleterious <italic>BRCA1</italic> or <italic>BRCA2</italic> germline mutations</p>
###xml 976 1092 976 1092 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="31">Clinicopathological features of Indonesian breast cancer patients with deleterious <italic>BRCA1</italic> or <italic>BRCA2</italic> germline mutations</p></caption>
###xml 1092 1099 1092 1099 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Patient</th>
###xml 1102 1103 1102 1103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1099 1103 1099 1103 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Age<sup>a</sup></th>
###xml 1103 1130 1103 1130 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Gene with germline mutation</th>
###xml 1138 1139 1138 1139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1130 1139 1130 1139 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Mutation<sup>b</sup></th>
###xml 1139 1144 1139 1144 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">stage</th>
###xml 1144 1153 1144 1153 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Diagnosis</th>
###xml 1153 1170 1153 1170 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Menopausal status</th>
###xml 1170 1194 1170 1194 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">family history of cancer</th>
###xml 1194 1209 1194 1209 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Survival status</th>
###xml 1092 1209 1092 1209 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Patient</th><th align="left">Age<sup>a</sup></th><th align="left">Gene with germline mutation</th><th align="left">Mutation<sup>b</sup></th><th align="left">stage</th><th align="left">Diagnosis</th><th align="left">Menopausal status</th><th align="left">family history of cancer</th><th align="left">Survival status</th></tr>
###xml 1092 1209 1092 1209 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Patient</th><th align="left">Age<sup>a</sup></th><th align="left">Gene with germline mutation</th><th align="left">Mutation<sup>b</sup></th><th align="left">stage</th><th align="left">Diagnosis</th><th align="left">Menopausal status</th><th align="left">family history of cancer</th><th align="left">Survival status</th></tr></thead>
###xml 1209 1211 1209 1211 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">AE</td>
###xml 1211 1213 1211 1213 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">25</td>
###xml 1213 1218 1213 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 1213 1218 1213 1218 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>BRCA1</italic></td>
###xml 1218 1233 1218 1233 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">c.2784_2785insT</td>
###xml 1233 1242 1233 1242 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IIIB/IIIA</td>
###xml 1242 1256 1242 1256 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IDC, bilateral</td>
###xml 1256 1259 1256 1259 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">pre</td>
###xml 1259 1261 1259 1261 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No</td>
###xml 1261 1268 1261 1268 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">DOD 9 w</td>
###xml 1209 1268 1209 1268 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">AE</td><td align="left">25</td><td align="left"><italic>BRCA1</italic></td><td align="left">c.2784_2785insT</td><td align="left">IIIB/IIIA</td><td align="left">IDC, bilateral</td><td align="left">pre</td><td align="left">No</td><td align="left">DOD 9 w</td></tr>
###xml 1268 1271 1268 1271 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">B10</td>
###xml 1271 1273 1271 1273 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">31</td>
###xml 1273 1278 1273 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 1273 1278 1273 1278 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>BRCA1</italic></td>
###xml 1278 1288 1278 1288 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">p.Leu1415X</td>
###xml 1288 1289 1288 1289 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">I</td>
###xml 1289 1292 1289 1292 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IDC</td>
###xml 1292 1295 1292 1295 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">pre</td>
###xml 1295 1297 1295 1297 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No</td>
###xml 1297 1305 1297 1305 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">DOD 57 w</td>
###xml 1268 1305 1268 1305 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">B10</td><td align="left">31</td><td align="left"><italic>BRCA1</italic></td><td align="left">p.Leu1415X</td><td align="left">I</td><td align="left">IDC</td><td align="left">pre</td><td align="left">No</td><td align="left">DOD 57 w</td></tr>
###xml 1305 1307 1305 1307 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">AA</td>
###xml 1307 1309 1307 1309 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">40</td>
###xml 1309 1314 1309 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 1309 1314 1309 1314 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>BRCA1</italic></td>
###xml 1315 1316 1315 1316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1314 1316 1314 1316 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">-<sup>c</sup></td>
###xml 1316 1320 1316 1320 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IIIB</td>
###xml 1320 1326 1320 1326 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IDC N+</td>
###xml 1326 1329 1326 1329 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">pre</td>
###xml 1329 1331 1329 1331 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No</td>
###xml 1331 1334 1331 1334 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">AWD</td>
###xml 1305 1334 1305 1334 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">AA</td><td align="left">40</td><td align="left"><italic>BRCA1</italic></td><td align="left">-<sup>c</sup></td><td align="left">IIIB</td><td align="left">IDC N+</td><td align="left">pre</td><td align="left">No</td><td align="left">AWD</td></tr>
###xml 1334 1336 1334 1336 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">AB</td>
###xml 1336 1338 1336 1338 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">34</td>
###xml 1338 1343 1338 1343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1338 1343 1338 1343 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>BRCA2</italic></td>
###xml 1343 1358 1343 1358 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">c.3040_3043del4</td>
###xml 1358 1362 1358 1362 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IIIB</td>
###xml 1362 1368 1362 1368 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IDC N+</td>
###xml 1368 1371 1368 1371 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">pre</td>
###xml 1371 1382 1371 1382 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Sister, Int</td>
###xml 1382 1390 1382 1390 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">DOD 17 w</td>
###xml 1334 1390 1334 1390 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">AB</td><td align="left">34</td><td align="left"><italic>BRCA2</italic></td><td align="left">c.3040_3043del4</td><td align="left">IIIB</td><td align="left">IDC N+</td><td align="left">pre</td><td align="left">Sister, Int</td><td align="left">DOD 17 w</td></tr>
###xml 1390 1392 1390 1392 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">B5</td>
###xml 1392 1394 1392 1394 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">63</td>
###xml 1394 1399 1394 1399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1394 1399 1394 1399 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>BRCA2</italic></td>
###xml 1399 1409 1399 1409 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">p.Glu2183X</td>
###xml 1409 1411 1409 1411 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IV</td>
###xml 1411 1418 1411 1418 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Tubular</td>
###xml 1418 1422 1418 1422 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">post</td>
###xml 1422 1431 1422 1431 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Sister,Br</td>
###xml 1431 1434 1431 1434 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">AWD</td>
###xml 1390 1434 1390 1434 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">B5</td><td align="left">63</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Glu2183X</td><td align="left">IV</td><td align="left">Tubular</td><td align="left">post</td><td align="left">Sister,Br</td><td align="left">AWD</td></tr>
###xml 1434 1436 1434 1436 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">B6</td>
###xml 1436 1438 1436 1438 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">65</td>
###xml 1438 1443 1438 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1438 1443 1438 1443 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>BRCA2</italic></td>
###xml 1443 1453 1443 1453 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">p.Glu2183X</td>
###xml 1453 1456 1453 1456 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">III</td>
###xml 1456 1459 1456 1459 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IDC</td>
###xml 1459 1463 1459 1463 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">post</td>
###xml 1463 1474 1463 1474 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Brother, Br</td>
###xml 1474 1477 1474 1477 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">AWD</td>
###xml 1434 1477 1434 1477 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">B6</td><td align="left">65</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Glu2183X</td><td align="left">III</td><td align="left">IDC</td><td align="left">post</td><td align="left">Brother, Br</td><td align="left">AWD</td></tr>
###xml 1477 1484 1477 1484 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">B-III-5</td>
###xml 1484 1486 1484 1486 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">30</td>
###xml 1486 1491 1486 1491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1486 1491 1486 1491 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>BRCA2</italic></td>
###xml 1491 1500 1491 1500 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">p.Leu824X</td>
###xml 1500 1501 1500 1501 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">I</td>
###xml 1501 1504 1501 1504 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IDC</td>
###xml 1504 1507 1504 1507 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">pre</td>
###xml 1507 1509 1507 1509 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No</td>
###xml 1509 1512 1509 1512 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">AWD</td>
###xml 1477 1512 1477 1512 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">B-III-5</td><td align="left">30</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Leu824X</td><td align="left">I</td><td align="left">IDC</td><td align="left">pre</td><td align="left">No</td><td align="left">AWD</td></tr>
###xml 1512 1514 1512 1514 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">AZ</td>
###xml 1514 1516 1514 1516 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">40</td>
###xml 1516 1521 1516 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1516 1521 1516 1521 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>BRCA2</italic></td>
###xml 1521 1530 1521 1530 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">p.Leu824X</td>
###xml 1530 1532 1530 1532 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IV</td>
###xml 1532 1535 1532 1535 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IDC</td>
###xml 1535 1538 1535 1538 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">pre</td>
###xml 1538 1548 1538 1548 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Sister, Cv</td>
###xml 1548 1556 1548 1556 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">DOD 46 w</td>
###xml 1512 1556 1512 1556 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">AZ</td><td align="left">40</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Leu824X</td><td align="left">IV</td><td align="left">IDC</td><td align="left">pre</td><td align="left">Sister, Cv</td><td align="left">DOD 46 w</td></tr>
###xml 1556 1560 1556 1560 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">W-II</td>
###xml 1560 1562 1560 1562 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">37</td>
###xml 1562 1567 1562 1567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1562 1567 1562 1567 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>BRCA2</italic></td>
###xml 1567 1577 1567 1577 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">p.Gln2894X</td>
###xml 1577 1581 1577 1581 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IIIA</td>
###xml 1581 1584 1581 1584 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IDC</td>
###xml 1584 1587 1584 1587 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">pre</td>
###xml 1587 1589 1587 1589 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No</td>
###xml 1589 1598 1589 1598 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">DOD 107 w</td>
###xml 1556 1598 1556 1598 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">W-II</td><td align="left">37</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Gln2894X</td><td align="left">IIIA</td><td align="left">IDC</td><td align="left">pre</td><td align="left">No</td><td align="left">DOD 107 w</td></tr>
###xml 1209 1598 1209 1598 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">AE</td><td align="left">25</td><td align="left"><italic>BRCA1</italic></td><td align="left">c.2784_2785insT</td><td align="left">IIIB/IIIA</td><td align="left">IDC, bilateral</td><td align="left">pre</td><td align="left">No</td><td align="left">DOD 9 w</td></tr><tr><td align="left">B10</td><td align="left">31</td><td align="left"><italic>BRCA1</italic></td><td align="left">p.Leu1415X</td><td align="left">I</td><td align="left">IDC</td><td align="left">pre</td><td align="left">No</td><td align="left">DOD 57 w</td></tr><tr><td align="left">AA</td><td align="left">40</td><td align="left"><italic>BRCA1</italic></td><td align="left">-<sup>c</sup></td><td align="left">IIIB</td><td align="left">IDC N+</td><td align="left">pre</td><td align="left">No</td><td align="left">AWD</td></tr><tr><td align="left">AB</td><td align="left">34</td><td align="left"><italic>BRCA2</italic></td><td align="left">c.3040_3043del4</td><td align="left">IIIB</td><td align="left">IDC N+</td><td align="left">pre</td><td align="left">Sister, Int</td><td align="left">DOD 17 w</td></tr><tr><td align="left">B5</td><td align="left">63</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Glu2183X</td><td align="left">IV</td><td align="left">Tubular</td><td align="left">post</td><td align="left">Sister,Br</td><td align="left">AWD</td></tr><tr><td align="left">B6</td><td align="left">65</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Glu2183X</td><td align="left">III</td><td align="left">IDC</td><td align="left">post</td><td align="left">Brother, Br</td><td align="left">AWD</td></tr><tr><td align="left">B-III-5</td><td align="left">30</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Leu824X</td><td align="left">I</td><td align="left">IDC</td><td align="left">pre</td><td align="left">No</td><td align="left">AWD</td></tr><tr><td align="left">AZ</td><td align="left">40</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Leu824X</td><td align="left">IV</td><td align="left">IDC</td><td align="left">pre</td><td align="left">Sister, Cv</td><td align="left">DOD 46 w</td></tr><tr><td align="left">W-II</td><td align="left">37</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Gln2894X</td><td align="left">IIIA</td><td align="left">IDC</td><td align="left">pre</td><td align="left">No</td><td align="left">DOD 107 w</td></tr></tbody>
###xml 1092 1598 1092 1598 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Patient</th><th align="left">Age<sup>a</sup></th><th align="left">Gene with germline mutation</th><th align="left">Mutation<sup>b</sup></th><th align="left">stage</th><th align="left">Diagnosis</th><th align="left">Menopausal status</th><th align="left">family history of cancer</th><th align="left">Survival status</th></tr></thead><tbody><tr><td align="left">AE</td><td align="left">25</td><td align="left"><italic>BRCA1</italic></td><td align="left">c.2784_2785insT</td><td align="left">IIIB/IIIA</td><td align="left">IDC, bilateral</td><td align="left">pre</td><td align="left">No</td><td align="left">DOD 9 w</td></tr><tr><td align="left">B10</td><td align="left">31</td><td align="left"><italic>BRCA1</italic></td><td align="left">p.Leu1415X</td><td align="left">I</td><td align="left">IDC</td><td align="left">pre</td><td align="left">No</td><td align="left">DOD 57 w</td></tr><tr><td align="left">AA</td><td align="left">40</td><td align="left"><italic>BRCA1</italic></td><td align="left">-<sup>c</sup></td><td align="left">IIIB</td><td align="left">IDC N+</td><td align="left">pre</td><td align="left">No</td><td align="left">AWD</td></tr><tr><td align="left">AB</td><td align="left">34</td><td align="left"><italic>BRCA2</italic></td><td align="left">c.3040_3043del4</td><td align="left">IIIB</td><td align="left">IDC N+</td><td align="left">pre</td><td align="left">Sister, Int</td><td align="left">DOD 17 w</td></tr><tr><td align="left">B5</td><td align="left">63</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Glu2183X</td><td align="left">IV</td><td align="left">Tubular</td><td align="left">post</td><td align="left">Sister,Br</td><td align="left">AWD</td></tr><tr><td align="left">B6</td><td align="left">65</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Glu2183X</td><td align="left">III</td><td align="left">IDC</td><td align="left">post</td><td align="left">Brother, Br</td><td align="left">AWD</td></tr><tr><td align="left">B-III-5</td><td align="left">30</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Leu824X</td><td align="left">I</td><td align="left">IDC</td><td align="left">pre</td><td align="left">No</td><td align="left">AWD</td></tr><tr><td align="left">AZ</td><td align="left">40</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Leu824X</td><td align="left">IV</td><td align="left">IDC</td><td align="left">pre</td><td align="left">Sister, Cv</td><td align="left">DOD 46 w</td></tr><tr><td align="left">W-II</td><td align="left">37</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Gln2894X</td><td align="left">IIIA</td><td align="left">IDC</td><td align="left">pre</td><td align="left">No</td><td align="left">DOD 107 w</td></tr></tbody></table>
###xml 1598 1599 1598 1599 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1598 1623 1598 1623 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32"><sup>a</sup>Age at time of diagnosis</p>
###xml 1623 1624 1623 1624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1651 1656 1651 1656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 1666 1671 1666 1671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 1623 1679 1623 1679 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="33"><sup>b</sup>Gen Bank Accession number, <italic>BRCA1</italic>: U14680, <italic>BRCA2</italic>: U43746</p>
###xml 1679 1680 1679 1680 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1679 1712 1679 1712 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="34"><sup>c</sup>not determined, detected by MLPA</p>
###xml 1712 1893 1712 1893 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35">IDC: invasive ductal carcinoma; DOD: dead of disease; bil: bilateral breast cancer; N+: with metastatic to lymph node; Int: intestinum cancer, Br: breast cancer; Cv: cervical cancer</p>
###xml 1598 1893 1598 1893 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32"><sup>a</sup>Age at time of diagnosis</p><p textid="33"><sup>b</sup>Gen Bank Accession number, <italic>BRCA1</italic>: U14680, <italic>BRCA2</italic>: U43746</p><p textid="34"><sup>c</sup>not determined, detected by MLPA</p><p textid="35">IDC: invasive ductal carcinoma; DOD: dead of disease; bil: bilateral breast cancer; N+: with metastatic to lymph node; Int: intestinum cancer, Br: breast cancer; Cv: cervical cancer</p></table-wrap-foot>
###xml 969 1893 969 1893 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="31">Clinicopathological features of Indonesian breast cancer patients with deleterious <italic>BRCA1</italic> or <italic>BRCA2</italic> germline mutations</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Patient</th><th align="left">Age<sup>a</sup></th><th align="left">Gene with germline mutation</th><th align="left">Mutation<sup>b</sup></th><th align="left">stage</th><th align="left">Diagnosis</th><th align="left">Menopausal status</th><th align="left">family history of cancer</th><th align="left">Survival status</th></tr></thead><tbody><tr><td align="left">AE</td><td align="left">25</td><td align="left"><italic>BRCA1</italic></td><td align="left">c.2784_2785insT</td><td align="left">IIIB/IIIA</td><td align="left">IDC, bilateral</td><td align="left">pre</td><td align="left">No</td><td align="left">DOD 9 w</td></tr><tr><td align="left">B10</td><td align="left">31</td><td align="left"><italic>BRCA1</italic></td><td align="left">p.Leu1415X</td><td align="left">I</td><td align="left">IDC</td><td align="left">pre</td><td align="left">No</td><td align="left">DOD 57 w</td></tr><tr><td align="left">AA</td><td align="left">40</td><td align="left"><italic>BRCA1</italic></td><td align="left">-<sup>c</sup></td><td align="left">IIIB</td><td align="left">IDC N+</td><td align="left">pre</td><td align="left">No</td><td align="left">AWD</td></tr><tr><td align="left">AB</td><td align="left">34</td><td align="left"><italic>BRCA2</italic></td><td align="left">c.3040_3043del4</td><td align="left">IIIB</td><td align="left">IDC N+</td><td align="left">pre</td><td align="left">Sister, Int</td><td align="left">DOD 17 w</td></tr><tr><td align="left">B5</td><td align="left">63</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Glu2183X</td><td align="left">IV</td><td align="left">Tubular</td><td align="left">post</td><td align="left">Sister,Br</td><td align="left">AWD</td></tr><tr><td align="left">B6</td><td align="left">65</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Glu2183X</td><td align="left">III</td><td align="left">IDC</td><td align="left">post</td><td align="left">Brother, Br</td><td align="left">AWD</td></tr><tr><td align="left">B-III-5</td><td align="left">30</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Leu824X</td><td align="left">I</td><td align="left">IDC</td><td align="left">pre</td><td align="left">No</td><td align="left">AWD</td></tr><tr><td align="left">AZ</td><td align="left">40</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Leu824X</td><td align="left">IV</td><td align="left">IDC</td><td align="left">pre</td><td align="left">Sister, Cv</td><td align="left">DOD 46 w</td></tr><tr><td align="left">W-II</td><td align="left">37</td><td align="left"><italic>BRCA2</italic></td><td align="left">p.Gln2894X</td><td align="left">IIIA</td><td align="left">IDC</td><td align="left">pre</td><td align="left">No</td><td align="left">DOD 107 w</td></tr></tbody></table><table-wrap-foot><p textid="32"><sup>a</sup>Age at time of diagnosis</p><p textid="33"><sup>b</sup>Gen Bank Accession number, <italic>BRCA1</italic>: U14680, <italic>BRCA2</italic>: U43746</p><p textid="34"><sup>c</sup>not determined, detected by MLPA</p><p textid="35">IDC: invasive ductal carcinoma; DOD: dead of disease; bil: bilateral breast cancer; N+: with metastatic to lymph node; Int: intestinum cancer, Br: breast cancer; Cv: cervical cancer</p></table-wrap-foot></table-wrap>
###xml 103 110 <span type="species:ncbi:9606">patient</span>
###xml 122 129 <span type="species:ncbi:9606">Patient</span>
###xml 691 698 <span type="species:ncbi:9606">patient</span>
###xml 1033 1041 <span type="species:ncbi:9606">patients</span>
One of seven pathogenic mutations found in BRCA1 and BRCA2 showed a significant clinical impact on the patient (Table 2). Patient AE with a one nucleotide insertion (Thymine) between nucleotide 2784 and 2785 (c.2784_2785insT) in exon 11 of BRCA1 suffered from bilateral breast cancer at a relatively early age (25 years). The insertion leads to frameshift and creates a premature stop codon in exon 11. The mutation takes place in the sequence within BRCA1 encoding for aminoacids 758-1064 which interact with RAD51 protein that is required for homologous recombination (HR) repair of double strand breaks (DSBs) [25], which is one of the most important functions of the BRCA1 protein. This patient presented in a late stage (stage III for both breasts) and only survived for 9 weeks after treatment. Her mother did not carry this mutation. Although her father may be carrier, the mutation is probably de novo as there was no family history of breast or other cancers. Table 2Clinicopathological features of Indonesian breast cancer patients with deleterious BRCA1 or BRCA2 germline mutationsPatientAgeaGene with germline mutationMutationbstageDiagnosisMenopausal statusfamily history of cancerSurvival statusAE25BRCA1c.2784_2785insTIIIB/IIIAIDC, bilateralpreNoDOD 9 wB1031BRCA1p.Leu1415XIIDCpreNoDOD 57 wAA40BRCA1-cIIIBIDC N+preNoAWDAB34BRCA2c.3040_3043del4IIIBIDC N+preSister, IntDOD 17 wB563BRCA2p.Glu2183XIVTubularpostSister,BrAWDB665BRCA2p.Glu2183XIIIIDCpostBrother, BrAWDB-III-530BRCA2p.Leu824XIIDCpreNoAWDAZ40BRCA2p.Leu824XIVIDCpreSister, CvDOD 46 wW-II37BRCA2p.Gln2894XIIIAIDCpreNoDOD 107 waAge at time of diagnosisbGen Bank Accession number, BRCA1: U14680, BRCA2: U43746cnot determined, detected by MLPAIDC: invasive ductal carcinoma; DOD: dead of disease; bil: bilateral breast cancer; N+: with metastatic to lymph node; Int: intestinum cancer, Br: breast cancer; Cv: cervical cancer
###end p 30
###begin p 31
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Clinicopathological features of Indonesian breast cancer patients with deleterious BRCA1 or BRCA2 germline mutations
###end p 31
###begin p 32
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aAge at time of diagnosis
###end p 32
###begin p 33
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
bGen Bank Accession number, BRCA1: U14680, BRCA2: U43746
###end p 33
###begin p 34
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
cnot determined, detected by MLPA
###end p 34
###begin p 35
IDC: invasive ductal carcinoma; DOD: dead of disease; bil: bilateral breast cancer; N+: with metastatic to lymph node; Int: intestinum cancer, Br: breast cancer; Cv: cervical cancer
###end p 35
###begin p 36
###xml 410 415 410 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 216 223 <span type="species:ncbi:9606">Patient</span>
The second pathogenic mutation with a significant clinical manifestation was a cytosine for thymine substitution on nucleotide 9008 of BRCA2 leading to a premature stop codon in position 2894, c9008C>T (p.Gln2894X). Patient W presented at age 37 in a late stage and survived for only 107 weeks after initial treatment. She had no family history of breast or other cancers. This mutation lies within exon 21 of BRCA2 which is the proposed site for interaction with the DSS1 protein that seems to have a fundamental role in enabling the BRCA2-RAD51 complex to associate with sites of DNA damage [26].
###end p 36
###begin p 37
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 214 219 214 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 391 396 391 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 461 466 461 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 866 871 866 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 144 151 <span type="species:ncbi:9606">patient</span>
###xml 481 488 <span type="species:ncbi:9606">Patient</span>
###xml 692 699 <span type="species:ncbi:9606">Patient</span>
###xml 819 826 <span type="species:ncbi:9606">patient</span>
###xml 1137 1145 <span type="species:ncbi:9606">patients</span>
The c.2699_2704delTAAATG (p.Leu824X) in BRCA2 that has been reported previously by us in the Indonesian population [17], was found in one other patient in the present study (Table 1). This mutation lies in exon 11 BRCA2, within the BRC repeats domain. The truncating mutation causes loss of three quarters of the protein leading to lack of interaction with the RAD51 protein. Different from BRCA1, the repair of DSBs by HR is the most important function of the BRCA2 protein [27]. Patient B-III-5 was diagnosed with early stage breast cancer at age 30 with no family history of breast or other cancers. Her sister carried the same mutation, but with no present clinical manifestation as yet. Patient AZ who was diagnosed at 40 years of age, presented in late stage, only survived 46 weeks after initial treatment. This patient also harbored a mutation in exon 16 of BRCA1, a G to A substitution in nucleotide 5075 (c.5075G>A), which leads to amino acid change from Methionine to Isoleucine, (p.Met16521Ile) which has to date been reported 35 times in BIC as a UV mutation. As the c.2699_2704delTAAATG mutation was found in two unrelated patients, this mutation could be a good candidate as a founder mutation.
###end p 37
###begin p 38
###xml 138 143 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 347 352 347 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
None of the families with more than 3 cases of breast cancer and families with bilateral breast cancer showed pathogenic mutations in the BRCA1 and BRCA2 genes. Family U had four first-degree relatives that were affected by breast cancer. Two of four members had bilateral breast cancer. In spite of this high familial breast cancer incidence, no BRCA1/2 mutations were found.
###end p 38
###begin title 39
BRCA1 and BRCA2 unclassified variants
###end title 39
###begin p 40
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 292 293 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 127 135 <span type="species:ncbi:9606">patients</span>
###xml 308 316 <span type="species:ncbi:9606">patients</span>
###xml 349 357 <span type="species:ncbi:9606">patients</span>
###xml 402 409 <span type="species:ncbi:9606">patient</span>
###xml 452 460 <span type="species:ncbi:9606">patients</span>
Sixteen (7 BRCA1 and 9 BRCA2) rare mutations of so far unknown significance ("unclassified variants", UVs) were detected in 18 patients: 13 missense changes and 3 intronic variants. Of these 16 UVs, 7 were novel, whereas the other UVs have been previously reported in the BIC database (Table 1). From the 18 patients which carried UV mutations, two patients were detected in families from group D; one patient in a group B family and the other fifteen patients in families from group A.
###end p 40
###begin p 41
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
Seven UV were found in the BRCA1 gene, two mutations occurring in the intronic region between exons 1 and 2 (c.101-10T>C) and between exons 19 and 20 (c.5313-31A>G), and five missense mutations identified: p.Val191Ile (c.690G>A), p.Leu1209Val (c.3744T>G), p.Met1652Ile (c.5075G>A), p.Arg1835Gln (c.5623G>A) and p.Thr1852Ile (c.5674C>T).
###end p 41
###begin p 42
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 820 825 820 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 835 837 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
Four out of seven BRCA1 missense mutations; p.Leu1209Val (c.3744T>G), c.5313-31A>G, p.Arg1835Gln (c.5623G>A) and p.Thr1852Ile (c.5674C>T) were have not been described previously in the BIC. The p.Leu1209Val may not be a significant change as both Leucine and Valine belong to the same group of non polar amino acids. However, p.Arg1835Gln is possibly an important alteration since a positively charged Arginine is replaced by an uncharged Glutamine, which may have an effect on the structure and/or function of the protein. Another potentially important alteration concerns p.Thr1852Ile, where the hydrophilic amino acid Threonine is replaced by a hydrophobic Isoleucine. The sites of mutation of both p.Arg1835Gln and p.Thr1852Ile also have to be considered as they lie within the site for the activation domain of the BRCA1 protein [28]. The intronic UV c.5313-31A>G also deserves further investigation as it may theoretically have an effect on splicing. However, according to splice site finder (http://www.genet.sickkids.on.ca/approximatelyali/splicesitefinder.html), the splicing sites in the wild type and mutant alleles are similar, so therefore we can suggest that the c.5313-31A>G has no effect on splicing.
###end p 42
###begin p 43
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 504 509 504 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
Nine different UVs of the BRCA2 gene were found in fourteen patients (Table1), and three of them were novel; p.Gln609Glu 9c.2053C>G), p.Gln699Leu (2324A>T) and p.Val950Ile (3076G>A). One truncating mutation near the C-terminal end of BRCA2, p.Lys3326X (c.10204A>T) is probably not pathogenic. Since the truncating mutation is at the very end of the protein, it is possible that protein functions are not affected. Most of the few entries in databanks describing nonsense mutations near the C terminus of BRCA2 between codon 3308 and 3408 are described as UVs. Thus, the effect of this truncating mutation on cancer predisposition remains unclear.
###end p 43
###begin p 44
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
The p.Val950Ile may not be a significant change as both Valine and Isoleucine belong to the same group of non polar, hydrophobic amino acids. However, p Gln609Glu and p.Gln699Leu are potentially important alterations as for p.Gln609Glu, a non acidic, polar, hydrophilic Glutamine is replaced by a negatively charged Glutamic acid, whereas for p.Gln699Leu, an uncharged hydrophilic Glutamine is replaced by a hydrophobic Leucine. As it takes place within the BRC repeats of the BRCA2 protein, the p Gln699Leu alteration might affect protein structure and function.
###end p 44
###begin p 45
###xml 161 249 161 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus, Rattus rattus, Bos taurus, Gallus gallus, Canis familiaris, Macaca mullata</italic>
###xml 254 276 254 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Monodelphis domestica.</italic>
###xml 563 573 563 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bos taurus</italic>
###xml 611 616 611 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 161 173 <span type="species:ncbi:10090">Mus musculus</span>
###xml 175 188 <span type="species:ncbi:10117">Rattus rattus</span>
###xml 190 200 <span type="species:ncbi:9913">Bos taurus</span>
###xml 202 215 <span type="species:ncbi:9031">Gallus gallus</span>
###xml 217 233 <span type="species:ncbi:9615">Canis familiaris</span>
###xml 254 275 <span type="species:ncbi:13616">Monodelphis domestica</span>
###xml 563 573 <span type="species:ncbi:9913">Bos taurus</span>
To know more about the importance of amino acid substitutions for protein function, we compared the amino acid sequence of interest in seven other species, i.e. Mus musculus, Rattus rattus, Bos taurus, Gallus gallus, Canis familiaris, Macaca mullata and Monodelphis domestica. The missense mutation p.Leu1209Val lies in the conserved region of exon 11 of the BRCA1 gene as the sequence is maintained in seven other species, whereas p.Arg1835Gln and p.Thr1852Ile are only conserved in four and three other species (comparison of p.Arg1835Gln and p.Thr1852Ile with Bos taurus sequence is not possible because the BRCA1 gene is shorter). Therefore, even tough the Leucine to Valine changes may not give any effect on amino acid charge, its conservation in evolution is suggestive of a functional role. Interestingly, p.Gln609Glu and p.Gln699Leu of BRCA2 that result in a quite dramatic amino acid subtitution that might lead to protein structure changes, are only conserved in four and five species respectively. As for the p.Val950Ile, the conservation in evolution is quite low. Although p.Gln609Glu is less conserved, we still believe that Glutamine to Glutamic acid substitution may have an effect on protein conformation as two adjacent acidic amino acids will be formed as the result of the substitution.
###end p 45
###begin p 46
Glycosylation moiety of an amino acid also plays a role in protein function. Amino acid substitutions involving Serine, Threonine and Asparagine, should also be checked for their O-GlcNac potential and threshold. Here we have a Threonine to Isoleucine substitution (p.Thr1852Ile) that after checking with YinOYang (http://www.cbs.dtu.dk/services/YinOYang) showed no significant threshold changes between the wildtype and the mutant allele.
###end p 46
###begin p 47
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 463 470 463 470 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;3</label>
###xml 531 536 531 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 541 546 541 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 470 592 470 592 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="48">The amino acid properties of novel unclassified mutations in <italic>BRCA1</italic> and <italic>BRCA2</italic> within an Indonesian breast cancer population</p>
###xml 470 592 470 592 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="48">The amino acid properties of novel unclassified mutations in <italic>BRCA1</italic> and <italic>BRCA2</italic> within an Indonesian breast cancer population</p></caption>
###xml 592 596 592 596 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Gene</th>
###xml 596 613 596 613 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Amino acid change</th>
###xml 613 629 613 629 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Change of charge</th>
###xml 629 655 629 655 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Change of amino acid group</th>
###xml 671 672 671 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 655 672 655 672 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Similarity score<sup>a</sup></th>
###xml 672 705 672 705 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"># species with conserved sequence</th>
###xml 592 705 592 705 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Gene</th><th align="left">Amino acid change</th><th align="left">Change of charge</th><th align="left">Change of amino acid group</th><th align="left">Similarity score<sup>a</sup></th><th align="left"># species with conserved sequence</th></tr>
###xml 592 705 592 705 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Gene</th><th align="left">Amino acid change</th><th align="left">Change of charge</th><th align="left">Change of amino acid group</th><th align="left">Similarity score<sup>a</sup></th><th align="left"># species with conserved sequence</th></tr></thead>
###xml 705 710 705 710 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">BRCA1</td>
###xml 710 720 710 720 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Leu to Val</td>
###xml 720 724 720 724 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">None</td>
###xml 724 726 724 726 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">No</td>
###xml 726 728 726 728 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">32</td>
###xml 729 742 729 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a,b,c,d,e,f,g</sup>
###xml 728 742 728 742 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7<sup>a,b,c,d,e,f,g</sup></td>
###xml 705 742 705 742 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">BRCA1</td><td char="." align="char">Leu to Val</td><td char="." align="char">None</td><td char="." align="char">No</td><td char="." align="char">32</td><td char="." align="char">7<sup>a,b,c,d,e,f,g</sup></td></tr>
###xml 742 747 742 747 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">BRCA1</td>
###xml 747 757 747 757 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Arg to Gln</td>
###xml 757 773 757 773 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Pos to no charge</td>
###xml 773 776 773 776 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Yes</td>
###xml 776 778 776 778 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">43</td>
###xml 779 786 779 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a,c,f,g</sup>
###xml 778 786 778 786 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4<sup>a,c,f,g</sup></td>
###xml 742 786 742 786 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">BRCA1</td><td char="." align="char">Arg to Gln</td><td char="." align="char">Pos to no charge</td><td char="." align="char">Yes</td><td char="." align="char">43</td><td char="." align="char">4<sup>a,c,f,g</sup></td></tr>
###xml 786 791 786 791 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">BRCA1</td>
###xml 791 801 791 801 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Thr to Ile</td>
###xml 801 819 801 819 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">polar to non polar</td>
###xml 819 822 819 822 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Yes</td>
###xml 822 824 822 824 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">89</td>
###xml 825 830 825 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a,c,g</sup>
###xml 824 830 824 830 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3<sup>a,c,g</sup></td>
###xml 786 830 786 830 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">BRCA1</td><td char="." align="char">Thr to Ile</td><td char="." align="char">polar to non polar</td><td char="." align="char">Yes</td><td char="." align="char">89</td><td char="." align="char">3<sup>a,c,g</sup></td></tr>
###xml 830 835 830 835 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">BRCA2</td>
###xml 835 845 835 845 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Gln to Glu</td>
###xml 845 861 845 861 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">No charge to neg</td>
###xml 861 864 861 864 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Yes</td>
###xml 864 866 864 866 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">29</td>
###xml 867 874 867 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a,b,c,g</sup>
###xml 866 874 866 874 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4<sup>a,b,c,g</sup></td>
###xml 830 874 830 874 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">BRCA2</td><td char="." align="char">Gln to Glu</td><td char="." align="char">No charge to neg</td><td char="." align="char">Yes</td><td char="." align="char">29</td><td char="." align="char">4<sup>a,b,c,g</sup></td></tr>
###xml 874 879 874 879 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">BRCA2</td>
###xml 879 889 879 889 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Gln to Leu</td>
###xml 889 907 889 907 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Polar to non polar</td>
###xml 907 910 907 910 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Yes</td>
###xml 910 913 910 913 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">113</td>
###xml 914 923 914 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a,b,d,e,f</sup>
###xml 913 923 913 923 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5<sup>a,b,d,e,f</sup></td>
###xml 874 923 874 923 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">BRCA2</td><td char="." align="char">Gln to Leu</td><td char="." align="char">Polar to non polar</td><td char="." align="char">Yes</td><td char="." align="char">113</td><td char="." align="char">5<sup>a,b,d,e,f</sup></td></tr>
###xml 923 928 923 928 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">BRCA2</td>
###xml 928 938 928 938 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">Val to Ile</td>
###xml 938 942 938 942 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">None</td>
###xml 942 944 942 944 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">No</td>
###xml 944 946 944 946 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">29</td>
###xml 947 950 947 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f,g</sup>
###xml 946 950 946 950 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2<sup>f,g</sup></td>
###xml 923 950 923 950 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">BRCA2</td><td char="." align="char">Val to Ile</td><td char="." align="char">None</td><td char="." align="char">No</td><td char="." align="char">29</td><td char="." align="char">2<sup>f,g</sup></td></tr>
###xml 705 950 705 950 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td char="." align="char">BRCA1</td><td char="." align="char">Leu to Val</td><td char="." align="char">None</td><td char="." align="char">No</td><td char="." align="char">32</td><td char="." align="char">7<sup>a,b,c,d,e,f,g</sup></td></tr><tr><td char="." align="char">BRCA1</td><td char="." align="char">Arg to Gln</td><td char="." align="char">Pos to no charge</td><td char="." align="char">Yes</td><td char="." align="char">43</td><td char="." align="char">4<sup>a,c,f,g</sup></td></tr><tr><td char="." align="char">BRCA1</td><td char="." align="char">Thr to Ile</td><td char="." align="char">polar to non polar</td><td char="." align="char">Yes</td><td char="." align="char">89</td><td char="." align="char">3<sup>a,c,g</sup></td></tr><tr><td char="." align="char">BRCA2</td><td char="." align="char">Gln to Glu</td><td char="." align="char">No charge to neg</td><td char="." align="char">Yes</td><td char="." align="char">29</td><td char="." align="char">4<sup>a,b,c,g</sup></td></tr><tr><td char="." align="char">BRCA2</td><td char="." align="char">Gln to Leu</td><td char="." align="char">Polar to non polar</td><td char="." align="char">Yes</td><td char="." align="char">113</td><td char="." align="char">5<sup>a,b,d,e,f</sup></td></tr><tr><td char="." align="char">BRCA2</td><td char="." align="char">Val to Ile</td><td char="." align="char">None</td><td char="." align="char">No</td><td char="." align="char">29</td><td char="." align="char">2<sup>f,g</sup></td></tr></tbody>
###xml 592 950 592 950 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Gene</th><th align="left">Amino acid change</th><th align="left">Change of charge</th><th align="left">Change of amino acid group</th><th align="left">Similarity score<sup>a</sup></th><th align="left"># species with conserved sequence</th></tr></thead><tbody><tr><td char="." align="char">BRCA1</td><td char="." align="char">Leu to Val</td><td char="." align="char">None</td><td char="." align="char">No</td><td char="." align="char">32</td><td char="." align="char">7<sup>a,b,c,d,e,f,g</sup></td></tr><tr><td char="." align="char">BRCA1</td><td char="." align="char">Arg to Gln</td><td char="." align="char">Pos to no charge</td><td char="." align="char">Yes</td><td char="." align="char">43</td><td char="." align="char">4<sup>a,c,f,g</sup></td></tr><tr><td char="." align="char">BRCA1</td><td char="." align="char">Thr to Ile</td><td char="." align="char">polar to non polar</td><td char="." align="char">Yes</td><td char="." align="char">89</td><td char="." align="char">3<sup>a,c,g</sup></td></tr><tr><td char="." align="char">BRCA2</td><td char="." align="char">Gln to Glu</td><td char="." align="char">No charge to neg</td><td char="." align="char">Yes</td><td char="." align="char">29</td><td char="." align="char">4<sup>a,b,c,g</sup></td></tr><tr><td char="." align="char">BRCA2</td><td char="." align="char">Gln to Leu</td><td char="." align="char">Polar to non polar</td><td char="." align="char">Yes</td><td char="." align="char">113</td><td char="." align="char">5<sup>a,b,d,e,f</sup></td></tr><tr><td char="." align="char">BRCA2</td><td char="." align="char">Val to Ile</td><td char="." align="char">None</td><td char="." align="char">No</td><td char="." align="char">29</td><td char="." align="char">2<sup>f,g</sup></td></tr></tbody></table>
###xml 950 951 950 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 993 995 993 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 950 1046 950 1046 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="49"><sup>a</sup>based on Grantham table [Grantham et&#160;al. [<xref ref-type="bibr" rid="CR29">29</xref>], a score above 100 indicates significance changes</p>
###xml 1046 1185 1046 1185 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="50">a&#160;=&#160;Macaca mullata, b&#160;=&#160;Bos taurus, c&#160;=&#160;Canis familiaris, d&#160;=&#160;Rattus rattus, e&#160;=&#160;Mus musculus, f&#160;=&#160;Gallus gallus, h&#160;=&#160;Monodelphis domestica</p>
###xml 950 1185 950 1185 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="49"><sup>a</sup>based on Grantham table [Grantham et&#160;al. [<xref ref-type="bibr" rid="CR29">29</xref>], a score above 100 indicates significance changes</p><p textid="50">a&#160;=&#160;Macaca mullata, b&#160;=&#160;Bos taurus, c&#160;=&#160;Canis familiaris, d&#160;=&#160;Rattus rattus, e&#160;=&#160;Mus musculus, f&#160;=&#160;Gallus gallus, h&#160;=&#160;Monodelphis domestica</p></table-wrap-foot>
###xml 463 1185 463 1185 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table&#160;3</label><caption><p textid="48">The amino acid properties of novel unclassified mutations in <italic>BRCA1</italic> and <italic>BRCA2</italic> within an Indonesian breast cancer population</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Gene</th><th align="left">Amino acid change</th><th align="left">Change of charge</th><th align="left">Change of amino acid group</th><th align="left">Similarity score<sup>a</sup></th><th align="left"># species with conserved sequence</th></tr></thead><tbody><tr><td char="." align="char">BRCA1</td><td char="." align="char">Leu to Val</td><td char="." align="char">None</td><td char="." align="char">No</td><td char="." align="char">32</td><td char="." align="char">7<sup>a,b,c,d,e,f,g</sup></td></tr><tr><td char="." align="char">BRCA1</td><td char="." align="char">Arg to Gln</td><td char="." align="char">Pos to no charge</td><td char="." align="char">Yes</td><td char="." align="char">43</td><td char="." align="char">4<sup>a,c,f,g</sup></td></tr><tr><td char="." align="char">BRCA1</td><td char="." align="char">Thr to Ile</td><td char="." align="char">polar to non polar</td><td char="." align="char">Yes</td><td char="." align="char">89</td><td char="." align="char">3<sup>a,c,g</sup></td></tr><tr><td char="." align="char">BRCA2</td><td char="." align="char">Gln to Glu</td><td char="." align="char">No charge to neg</td><td char="." align="char">Yes</td><td char="." align="char">29</td><td char="." align="char">4<sup>a,b,c,g</sup></td></tr><tr><td char="." align="char">BRCA2</td><td char="." align="char">Gln to Leu</td><td char="." align="char">Polar to non polar</td><td char="." align="char">Yes</td><td char="." align="char">113</td><td char="." align="char">5<sup>a,b,d,e,f</sup></td></tr><tr><td char="." align="char">BRCA2</td><td char="." align="char">Val to Ile</td><td char="." align="char">None</td><td char="." align="char">No</td><td char="." align="char">29</td><td char="." align="char">2<sup>f,g</sup></td></tr></tbody></table><table-wrap-foot><p textid="49"><sup>a</sup>based on Grantham table [Grantham et&#160;al. [<xref ref-type="bibr" rid="CR29">29</xref>], a score above 100 indicates significance changes</p><p textid="50">a&#160;=&#160;Macaca mullata, b&#160;=&#160;Bos taurus, c&#160;=&#160;Canis familiaris, d&#160;=&#160;Rattus rattus, e&#160;=&#160;Mus musculus, f&#160;=&#160;Gallus gallus, h&#160;=&#160;Monodelphis domestica</p></table-wrap-foot></table-wrap>
###xml 1070 1080 <span type="species:ncbi:9913">Bos taurus</span>
###xml 1086 1102 <span type="species:ncbi:9615">Canis familiaris</span>
###xml 1108 1121 <span type="species:ncbi:10117">Rattus rattus</span>
###xml 1127 1139 <span type="species:ncbi:10090">Mus musculus</span>
###xml 1145 1158 <span type="species:ncbi:9031">Gallus gallus</span>
###xml 1164 1185 <span type="species:ncbi:13616">Monodelphis domestica</span>
The possible effect of amino acid changes in proteins can also be assessed using similarity scores (based on Grantham table [29]), in which a value above 100 for an amino acid substitution indicates a higher chance of impact on protein function. Among seven novel UVs in the BRCA1 and BRCA2 genes found in the present study, only p.Gln699Leu in BRCA2 has a similarity score above 100, whereas p.Gln609Glu and p.Val905Ile in BRCA2 have the lowest score (Table 3). Table 3The amino acid properties of novel unclassified mutations in BRCA1 and BRCA2 within an Indonesian breast cancer populationGeneAmino acid changeChange of chargeChange of amino acid groupSimilarity scorea# species with conserved sequenceBRCA1Leu to ValNoneNo327a,b,c,d,e,f,gBRCA1Arg to GlnPos to no chargeYes434a,c,f,gBRCA1Thr to Ilepolar to non polarYes893a,c,gBRCA2Gln to GluNo charge to negYes294a,b,c,gBRCA2Gln to LeuPolar to non polarYes1135a,b,d,e,fBRCA2Val to IleNoneNo292f,gabased on Grantham table [Grantham et al. [29], a score above 100 indicates significance changesa = Macaca mullata, b = Bos taurus, c = Canis familiaris, d = Rattus rattus, e = Mus musculus, f = Gallus gallus, h = Monodelphis domestica
###end p 47
###begin p 48
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
The amino acid properties of novel unclassified mutations in BRCA1 and BRCA2 within an Indonesian breast cancer population
###end p 48
###begin p 49
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 43 45 43 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
abased on Grantham table [Grantham et al. [29], a score above 100 indicates significance changes
###end p 49
###begin p 50
###xml 24 34 <span type="species:ncbi:9913">Bos taurus</span>
###xml 40 56 <span type="species:ncbi:9615">Canis familiaris</span>
###xml 62 75 <span type="species:ncbi:10117">Rattus rattus</span>
###xml 81 93 <span type="species:ncbi:10090">Mus musculus</span>
###xml 99 112 <span type="species:ncbi:9031">Gallus gallus</span>
###xml 118 139 <span type="species:ncbi:13616">Monodelphis domestica</span>
a = Macaca mullata, b = Bos taurus, c = Canis familiaris, d = Rattus rattus, e = Mus musculus, f = Gallus gallus, h = Monodelphis domestica
###end p 50
###begin p 51
Overall, we propose that among the seven novel UVs, there are three mutations that are possibly pathogenic: p.Leu1209Val for its location in a conserved region, and p.Gln609Glu and the p.Gln699Leu because of two adjacent acidic amino acid being formed and a high similarity score, respectively.
###end p 51
###begin p 52
###xml 113 120 113 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1/2</italic>
###xml 281 282 281 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 88 96 <span type="species:ncbi:9606">patients</span>
###xml 345 353 <span type="species:ncbi:9606">patients</span>
###xml 499 507 <span type="species:ncbi:9606">patients</span>
When comparing the three different Indonesian regions, the percentages of breast cancer patients with pathogenic BRCA1/2 mutations was significantly higher in Denpasar (Bali island) than in Jogjakarta and Jakarta (Java island) ((25% (3/12), 7.2% (6/83) and 0% (0/25) respectively (P = 0.0255, chi-square test)). The percentages of breast cancer patients with UV mutations in Jakarta, Jogjakarta, and Denpasar were 16% (4/25), 12% (10/83), and 25% (3/12), respectively (n.s.). Although the number of patients is too small to draw firm conclusions, these data may point to geographic differences within Indonesia.
###end p 52
###begin p 53
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 654 659 654 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 440 448 <span type="species:ncbi:9606">patients</span>
###xml 475 483 <span type="species:ncbi:9606">patients</span>
###xml 542 550 <span type="species:ncbi:9606">patients</span>
###xml 746 754 <span type="species:ncbi:9606">patients</span>
It was initially suggested that the BRCA1 and BRCA2 genes would be responsible for most cases of inherited breast cancer, but more recent studies suggest that they would account for a far smaller proportion, with considerable variation among different populations [30]. We found that the incidence of mutations in these genes varies, depending on the diagnostic group. In this sense, mutations were present in (22/102) 21.6% of early onset patients (group A), 28.7% (2/7) in patients with bilateral breast cancer (group D) and (2/9) 22.2% of patients with two cases of breast cancer before the age of 60 (group B). The proportion of families affected by BRCA1/2 mutations depends on the population analyzed and on the criteria used to select the patients. Family history of breast cancer was, however, absent or not suggestive of a hereditary predisposition in three-fourth of the deleterious mutations carriers and in more than 90% of UV carriers. This suggests that BRCA screening policies based on family history only would miss a considerable proportion of mutation carriers.
###end p 53
###begin p 54
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 138 144 138 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2.</italic>
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA1</italic>
###xml 181 186 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRCA2</italic>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
In conclusion, a relatively high percentage of early onset Indonesian breast cancer patients carry a germline mutation in either BRCA1 or BRCA2. Several novel, pathogenic BRCA1 and BRCA2 germline mutations have been found, as well as a variety of novel "unclassified variant" mutations that may therefore be specific for the Indonesian population. It is likely that some of the "unclassified variant" mutations may have a functional role in breast cancer development, which deserves to be explored further.
###end p 54
###begin title 55
Acknowledgements
###end title 55
###begin p 56
Supported by grant IN-2001-008 of the Dutch Cancer Society. We thank dr. Jo Hilgers who has been instrumental in setting up the Familial Cancer Clinic initiative in Jogjakarta, and Jan Schouten for the technical support.
###end p 56
###begin title 57
References
###end title 57
###begin article-title 58
The contribution of inherited predisposition to cancer incidence
###end article-title 58
###begin article-title 59
The genetic attributable risk of breast and ovarian cancer
###end article-title 59
###begin article-title 60
Linkage of early-onset familial breast cancer to chromosome 17q21
###end article-title 60
###begin article-title 61
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
###end article-title 61
###begin article-title 62
Identification of the breast cancer susceptibility gene BRCA2
###end article-title 62
###begin article-title 63
In search of the tumour-suppressor functions of BRCA1 and BRCA2
###end article-title 63
###begin article-title 64
Lessons learned from BRCA1 and BRCA2
###end article-title 64
###begin article-title 65
The genetics of breast cancer susceptibility
###end article-title 65
###begin article-title 66
Hereditary predisposition to breast cancer
###end article-title 66
###begin article-title 67
A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening
###end article-title 67
###begin article-title 68
###xml 27 32 <span type="species:ncbi:9606">women</span>
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing
###end article-title 68
###begin article-title 69
Common BRCA1 variants and transcriptional activation
###end article-title 69
###begin article-title 70
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
###end article-title 70
###begin article-title 71
Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families
###end article-title 71
###begin article-title 72
A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families
###end article-title 72
###begin article-title 73
###xml 75 83 <span type="species:ncbi:9606">patients</span>
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients
###end article-title 73
###begin article-title 74
A novel BRCA2 mutation in an Indonesian family found with a new, rapid, and sensitive mutation detection method based on pooled denaturing gradient gel electrophoresis and targeted sequencing
###end article-title 74
###begin article-title 75
###xml 55 60 <span type="species:ncbi:9606">human</span>
A simple salting out procedure for extracting DNA from human nucleated cells
###end article-title 75
###begin article-title 76
Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification
###end article-title 76
###begin article-title 77
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study
###end article-title 77
###begin article-title 78
Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2
###end article-title 78
###begin article-title 79
###xml 43 48 <span type="species:ncbi:9606">women</span>
Novel germline BRCA1 mutations detected in women in singapore who developed breast carcinoma before the age of 36 years
###end article-title 79
###begin article-title 80
Collaboration of breast cancer clinic and genetic counseling division for BRCA1 and BRCA2 mutation family in Japan
###end article-title 80
###begin article-title 81
###xml 54 67 <span type="species:ncbi:4932">S. cerevisiae</span>
Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein
###end article-title 81
###begin article-title 82
DSS1 is required for RAD51 focus formation and genomic stability in mammalian cells
###end article-title 82
###begin article-title 83
BRCA2: breaks, mistakes and failed separations
###end article-title 83
###begin article-title 84
Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair-perhaps through transcription
###end article-title 84
###begin article-title 85
Amino acid difference formula to help explain protein evolution
###end article-title 85
###begin article-title 86
Population genetics of BRCA1 and BRCA2
###end article-title 86

